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Abstract
This qualitative description study is a sub-study of a knowledge translation (KT) project to
implement evidence-based blood transfusion practices at an urban tertiary hospital. The goals of
the KT project are to reduce the use of pre-transfusion medications (premedication) and improve
transfusion reaction (TR) reporting practices at this institution. This study explored the nursing
practices and perspectives of premedication and TR reporting by conducting interviews with 25
nurses. The findings showed a lack of standardized premedication and TR reporting practices at
this institution. A practice change is needed to achieve the goals of the KT project. The study
also revealed that nurses lack knowledge about evidence against the use of premedication and
lack awareness of the importance of TR reporting. Barriers and facilitators to reducing
premedication and improving TR reporting were identified. In conclusion, this study serves as a
needs and barriers assessment of the KT project. It also contributes to the literature by exploring
novel topics in the field of transfusion research.

Keywords
Blood transfusion, clinical practice, knowledge translation, nursing, premedication, qualitative
description, qualitative research, transfusion reaction reporting.
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Summary for Lay Audience
Blood transfusion is a common and life-saving treatment to certain patient populations. Each
time a transfusion is administered, there is a risk for the patient to develop transfusion-related
adverse reactions (TRs). Despite evidence suggesting the lack of efficacy and cost-effectiveness
of pre-transfusion medications (premedication), premedication is routinely prescribed to patients
as a means to prevent TRs in Canada. In addition, although TRs should be reported to a
hospital’s blood bank to ensure transfusion safety, under-reporting of TRs exists. Literature also
shows that health care professionals in Canada have poor awareness of the importance of
reporting TRs.
Based on the current best evidence against premedication, a knowledge translation (KT) project
is undertaken at a large urban tertiary hospital to reduce the use of premedication. The KT
project also aims to improve TR reporting practices at this institution because good TR reporting
practices are a foundation of evidence-based transfusion practices. As a sub-study of the KT
project, this qualitative description study explored the nursing practices and perspectives of
premedication and TR reporting by interviewing 25 nurses at this institution. The findings
showed a lack of standardized premedication and TR reporting practices at this institution. A
practice change is needed to achieve evidence-based transfusion practices. This study also
revealed that nurses at this institution lack knowledge about evidence against premedication and
lack awareness of the importance of TR reporting.
In conclusion, this study serves as a needs and barriers assessment of the overall KT project to
reduce premedication and improve TR reporting practices at this institution. Identified barriers
and facilitators will help tailor interventions to implement practice change at this institution. This
study also contributes to the literature by exploring new topics in the field of transfusion
research.
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Chapter 1

1

Introduction

This chapter first introduces the field of knowledge translation and provides a background of
issues of evidence-based transfusion practices. Then, the knowledge translation project
undertaken at the studied institution is described. As a sub-study of the project, this study’s
research questions and objectives are discussed. This chapter concludes with a description of the
structure of the thesis.

1.1 Knowledge Translation
Facing a population with increasing chronic and complex health conditions, health care systems
have a growing focus on evidence-based medicine which incorporates research-derived
knowledge into action to improve efficiency and quality of patient care (Kothari & Wathen,
2013; Straus, Tetroe, & Graham, 2009). However, despite significant resources devoted to health
sciences research, it is well documented in the literature that health care practitioners,
administrators and policy-makers have challenges of using research evidence in their decisionmaking processes and many patients do not receive the best possible care (Graham et al., 2006;
Grol & Grimshaw, 2003). Recognition of the knowledge-to-action gap, along with the emerging
emphasis on research accountability, has stimulated interest in knowledge translation (KT). KT
is formally defined by the Canadian Institutes of Health Research (CIHR) as a dynamic and
iterative process that includes the synthesis, dissemination, exchange and ethically-sound
application of knowledge to improve health, provide more effective health services and products
and strengthen the health care system (Canadian Institute for Health Research [CIHR], 2007).

Knowledge-to-Action Process
Consistent with CIHR’s (2007) definition of KT, Graham et al.’s (2006) conceptual framework
describes the knowledge-to-action (KTA) process as a complex and dynamic process composed
of two concepts: knowledge creation and action (Figure 1). Knowledge creation is the distillation
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of knowledge to find the core evidence potentially useful to its end-users, while the action cycle
is a seven-phase process that includes:
1) Identify the problem and the need for change
2) Select relevant knowledge and adapt identified knowledge to local context
3) Assess barriers to using the knowledge
4) Select, tailor, and implement interventions to promote the use of knowledge
5) Monitor knowledge use
6) Evaluate the outcomes of using the knowledge
7) Sustain ongoing knowledge use (Graham et al., 2006)

Figure 1: Knowledge-to-Action Process. Reprint from “Lost in knowledge translation:
Time for a map?” by Graham, I. et al., 2006, Journal of Continuing Education in the Health
Professions, 26(1), p. 13-24. Reprint with permission (Appendix A).
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1.2 Issues of Evidence-based Transfusion Practices
Blood transfusion is a common and life-saving treatment to certain patient populations. Each
time a transfusion is administered, there is a risk for the patient to develop transfusion-related
acute adverse events, known as transfusion reactions (TRs). The most common TRs are fevers
and minor allergic reactions (MARs) (Geiger & Howard, 2007). Although relatively benign,
fevers and MARs may cause unwanted interruptions in blood-product administration, discomfort
and anxiety for patients, and additional costs for health care systems (Duran, Siddique, & Cleary,
2014; Geiger & Howard, 2007). Therefore, preventing fevers and MARs are desirable goals
(Geiger & Howard, 2007; Solh, Chan, & Heddle, 2016).
Administering pre-transfusion medications (termed premedication) is a common practice used
for the prevention of fever and MARs in transfusions (Duran et al., 2014; Fry et al., 2010).
However, evidence from randomized controlled trials and a systematic review indicates that the
use of premedication does not reduce the incidence of fever and MARs in transfusions
(Kennedy, Case, Hurd, Cruz, & Pomper, 2008; Marti-Carvajal, Sola, Gonzalez, Leon de
Gonzalez, & Rodriguez-Malagon, 2010; Rujkijyanont, Monsereenusorn, Manoonphol, &
Traivaree, 2018; Wang et al., 2002). Furthermore, studies have shown that the use of
premedication is not cost-effective for patients, health care professionals and hospitals
(Christensen, Rubinstein, Bastakoty, Savani, & Booth, 2019; Ezidiegwu, Lauenstein, Rosales,
Kelly, & Henry, 2004; Sanders et al., 2005). Despite current best evidence suggesting the lack of
efficacy and cost-effectiveness of premedication, premedication is still a common practice in
North America, with 50% to 80% of all administered transfusions being premedicated
(Ezidiegwu et al., 2004; Fry et al., 2010; Heddle et al., 1993).
Besides the routine use of premedication in an attempt to reduce TR, a national hemovigilance
system was implemented in Canada to monitor TRs and to ensure transfusion safety (Duncan,
2018). The functioning of this hemovigilance system relies on Canadian hospitals to voluntarily
report TRs to the system. Good TR reporting practices are considered an important foundation of
evidence-based transfusion practices (Solh et al., 2016). However, studied have found that TR
reporting rates vary and under-reporting of minor TRs such as fevers and MARs exists (Narvios,
Lichtiger, & Newman, 2004; Vossoughi et al., 2019).

4

The literature on health care professionals’ practices and perspectives of premedication and TR
reporting is limited. To the best of our knowledge, a national survey conducted in 16 Canadian
paediatric hospitals was the only study that assessed physicians’ practices and views regarding
premedication and TR reporting (Solh et al., 2016). Participants’ responses showed the lack of
standardized premedication practices across Canada and poor awareness of the importance of
reporting TRs (Solh et al., 2016). Furthermore, clinical guidelines on premedication and standard
order sets are not available in most hospitals but were identified as desirable future steps to
standardize premedication practices (Solh et al., 2016).

1.3 Overview of the KT Project
Based on current best evidence on premedication and TR reporting practices, a KT project has
been undertaken at a large urban tertiary academic hospital to implement evidence-based
transfusion practices. The goals of this KT project are to reduce the use of premedication and to
improve TR reporting practices in order to enhance transfusion safety and health outcomes of
transfused patients at this institution.
This KT project is based on Graham et al.’s (2006) KTA framework (Section 1.1.1). The first
part of the KTA process, knowledge creation, involves a distillation of knowledge to find the
core evidence useful to the knowledge users. Specifically for this KT project, knowledge
creation is the process in which the researchers conducted an extensive literature review on the
research about premedication and TR reporting. Through inquiring and synthesizing knowledge
from the literature, the researchers learned that premedication is a common practice that lacks
evidence supporting its efficacy and cost-effectivess (Duran et al., 2014; Ezidiegwu et al., 2004;
Marti-Carvajal et al., 2010). The researchers also recognized that TRs are under-reported or
reported incorrectly at various health care institutions (Narvios et al., 2004; Vossoughi et al.,
2019). With knowledge created and the gap between knowledge and action identified, the KT
team comprising researchers and clinicians decided to initiate the action cycle to bring about
practice change at this institution.
The first and fourth phases of Graham et al.’s (2006) action cycle, the needs assessment and the
barriers assessment, are particularly relevant to this study. In this study, the needs assessment
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phase involves the KT team, who is aware of evidence on premedication and TR reporting,
determining whether there is a knowledge-practice gap at this institution that needs to be
addressed (Graham et al., 2006). Meanwhile, the barriers assessment phase involves the KT team
identifying potential barriers that may impede the knowledge uptake and potential facilitators
that may encourage the knowledge uptake (Graham et al., 2006). Barriers and facilitators may be
related to the knowledge to be adopted, the potential adopters, and the context in which the
knowledge is to be used (Graham et al., 2006). Identified barriers and facilitators may be targeted
and hopefully overcome or utilized by designing tailored intervention strategies (Graham et al.,
2006).

1.4 Research Questions and Objectives
As a sub-study of the overall KT project, this study aimed to understand current premedication
practices and TR reporting practices at the studied institution. By exploring current practices, the
researchers sought to determine whether there is a need for practice change. This study also
aimed to explore nursing perspectives on premedication and TR reporting in order to identify
barriers and facilitators to implementing practice change at this institution. Thus, two research
questions guiding this study were:
1) Is there a need for practice chance to achieve evidence-based transfusion practices at
this institution?
2) What are the barriers and facilitators to reducing premedication and improving TR
reporting at this institution?
To answer these two research questions, this study used a qualitative description approach to
explore the nursing practices and perspectives of premedication and TR reporting. Specifically,
this study’s objectives are to understand the following aspects:
1) What are the current practices of administering transfusion premedication at this
institution? Who are involved in the process of administering premedication?
2) What are the factors impacting a health care professional’s decision on whether or not
to premedicate a patient?
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3) What are nurses’ perspectives on premedication? Are they aware of evidence against
the use of premedication? What are their perceived benefits and risks of
premedication?
4) What are the current practices of reporting TRs at this institution? Who are involved in
the TR reporting process?
5) What are the factors impacting the TR reporting practices at this institution?
6) What are nurses’ perspectives on TR reporting? What are their perceived barriers and
facilitators to reporting TRs?

1.5 Structure of the Thesis
Chapter 1 provides an introduction to the field of KT, the overall KT project, and the research
questions and objectives of this study. Chapter 2 expands on Chapter 1’s topics and provides a
literature review on areas relevant to this study. Chapter 3 describes the methodology and
methods used to conduct this study. Chapter 4 presents the results of this study. Lastly, Chapter 5
discusses the study’s findings, contributions, strengths, limitations, and implications and
provides a conclusion of this study.
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Chapter 2

2

Literature Review

This chapter provides a review of the literature relevant to the topics informing this study,
including blood transfusion and transfusion reactions, premedication, hemovigilance and TR
reporting.

2.1 Transfusion and Transfusion Reactions
A blood transfusion is a medical procedure in which whole blood or blood components from a
blood donor are infused into a patient’s bloodstream through a vein (National Heart, Lung, and
Blood Institute [NHLBI], n.d.). Transfusion is a common and lifesaving treatment to certain
patient populations and is given to restore lost blood, to improve clotting time in a bleeding
patient, or to improve the ability of the blood to deliver oxygen to body tissues (NHLBI, n.d.).
The most commonly transfused blood components are red blood cells, plasma, platelets and
cryoprecipitate (Clarke, 2017). In Canada, blood components are processed at the Canadian
Blood Services and provided to health care institutions for storage in their Transfusion Medicine
Laboratories (TMLs). Blood transfusions must be prescribed by a physician or authorized health
care professional after appropriate patient consent is obtained (Lima, 2015).
Every time a transfusion is administered, there is a risk for the patient to develop adverse TRs.
Acute TRs usually occur during or up to six hours following the end of transfusion and may
present with: 1) fever; 2) shaking chills or rigors with or without fever; 3) hives, rash, itchiness,
or swelling; 4) shortness of breath or wheezing; 5) hypotension or hypertension; 6) red urine,
diffuse bleeding or oozing; 7) lumbar pain, anxiety, pain at the intravenous site; 8) nausea and
vomiting; 9) headache; and 10) irritability in paediatric population (Lima, 2015). In rare
situations, the patient may develop life-threatening TRs such as ABO blood group
incompatibility-induced hemolysis, transfusion-associated sepsis, circulatory overload, and
transfusion-related acute lung injury (Perrotta & Snyder, 2001).
The most common TRs are febrile non-hemolytic transfusion reactions (referred to as fevers for
the rest of the thesis) and minor allergic reactions (MARs) (Geiger & Howard, 2007). At the
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studied institution, the institutional guideline defines a fever as meeting three criteria: 1) when
the patient’s body temperature is greater than or equal to (≥) 38 C; 2) when the body
temperature increases more than 1C from baseline temperature; and 3) when the fever occurs
during or up to four hours post-transfusion (London Health Sciences Centre & St. Joseph’s
Health Care London [LHSC & SJHCL], 2005). If a febrile symptom meets all three criteria, the
health care professional should follow the guideline to manage the fever and report the fever to
the TML. Usually, nurses would be the health care professionals in charge of TR management
and reporting (Hussain, Moiz, Ausat, & Khurshid, 2015). An allergic reaction may be associated
with hives, facial edema, airway edema, lower respiratory tract symptoms, hypotension, or shock
(Callum et al., 2017). The most common allergic reactions are MARs, which are characterized
by hives without respiratory or cardiovascular compromise (Geiger & Howard, 2007). At this
institution, the institutional guideline defines a MAR as a hive that covers less than two-thirds of
the body surface (LHSC & SJHCL, 2005). If a hive covers more than two-thirds of the body
surface, the symptom is defined as a severe allergic reaction (LHSC & SJHCL, 2005). Both
minor and severe allergic reactions should be managed according to the institutional practice
guideline and reported to the TML (LHSC & SJHCL, 2005).
Fevers and MARs are fortunately among the least harmful TRs. Although relatively benign,
fevers and MARs may cause unwanted interruptions in blood-product administration, discomfort
and anxiety for patients, and additional cost and resources for health care systems (Duran et al.,
2014; Geiger & Howard, 2007). Therefore, preventing fevers and MARs are desirable goals
(Geiger & Howard, 2007; Solh et al., 2016). In an earlier time, fevers occurred in up to 30% of
transfusions (Heddle et al., 1993). In the past decade, emphasis has been placed on the
prevention of fevers using strategies like leukocyte reduction (termed leukoreduction), which is a
blood processing technique with proven effectiveness (King et al., 2004; Paglino, Pomper, Fisch,
Champion, & Snyder, 2004; Pruss et al., 2004; Yazer, Podlosky, Clarke, & Nahirniak, 2004). In
recent years, since leukoreduction processing has been universally appc to platelets and red
blood cells, the risks of developing fevers during transfusions have decreased significantly to
0.03% to 2.18% of transfusions (Ezidiegwu et al., 2004; Heddle et al., 1993; King et al., 2004;
Paglino et al., 2004; Pruss et al., 2004; Yazer et al., 2004). Although evidence supports the
effectiveness of leukoreduction in reducing incidences of fevers, studied showed that
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leukoreduction is not an effective strategy to prevent allergic reactions including MARs (Paglino
et al., 2004; Pruss et al., 2004). Allergic reactions occur in less than 1% of transfusions (Paglino
et al., 2004; Pruss et al., 2004).

2.2 Premedication
Administering premedication is the most common bedside practice for the prevention of
transfusion-related fevers and MARs (Duran et al., 2014; Fry et al., 2010; Geiger & Howard,
2007). Usually, acetaminophen is prescribed to prevent fevers and diphenhydramine is
prescribed to prevent MARs (Duran et al., 2014; Fry et al., 2010). Acetaminophen is a drug with
potent antipyretic and analgesic properties but with very weak anti-inflammatory properties
(Botting, 2000). Acetaminophen is known to cause liver toxicity with acute overdose and liver
damage after repeated overdose (Hinson, Reid, McCullough, & James, 2004). Diphenhydramine
is a first-generation antihistamine drug used for treating acute allergic reactions (Banerji, Long,
& Camargo, 2007). Diphenhydramine crosses the blood-brain barrier and penetrates the central
nervous system, which causes drowsiness, affects alertness, and impairs cognitive and
psychomotor performance of the patient (Banerji et al., 2007; Hawkins & Egleton, 2008; Verster
et al., 2003). Diphenhydramine may also cause more severe symptoms like cardiotoxicity and
arrhythmias (Ramachandran & Sirop, 2008). Thus, the use of acetaminophen and
diphenhydramine as premedication is not entirely safe and benign. Nevertheless, due to their
pharmacological actions mentioned above, acetaminophen and diphenhydramine are
hypothesized to work for the prevention of fevers and MARs and are used for this purpose
during transfusions (Geiger & Howard, 2007).
The use of premedication is widespread. Health care providers in the United States prescribe
acetaminophen and diphenhydramine prior to more than 50% of all administered transfusions
(Ezidiegwu et al., 2004; Fry et al., 2010; Geiger & Howard, 2007). A national survey conducted
in Canada revealed a lack of standardized premedication practices in Canadian paediatric
hospitals (Solh et al., 2016). A Canadian institution reported a premedication rate of 73%, which
decreased to 50% after the implementation of institutional premedication guidelines (Patterson et
al., 2000).
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Although premedication has been a routine approach in TR prevention, there is controversy in
the literature about the use of premedication. Little evidence supports the efficacy of
premedication in reducing the risk of transfusion-related fevers and MARs. A study found that
fevers and allergic reactions were rare in paediatric patients who were transfused with
leukoreduced blood products, regardless of whether or not premedication was used (Sanders et
al., 2005). Three prospective randomized double-blind placebo-controlled trials comprising a
total of 513 patients have assessed the efficacy of acetaminophen and diphenhydramine used as
premedication in a variety of patient populations (Kennedy et al., 2008; Rujkijyanont et al.,
2018; Wang et al., 2002). All three randomized controlled trials found that premedication does
not significantly decrease the incidence of TRs compared to placebo (Kennedy et al., 2008;
Rujkijyanont et al., 2018; Wang et al., 2002). According to a recent Cochrane review of three
randomized controlled trials with moderate risk of bias, current evidence indicates that
premedication in any regimen does not reduce the risk of fevers and allergic reactions in
transfusions (Marti-Carvajal et al., 2010). The only known contradicting evidence is from
Ezidiegwu et al.'s (2004) retrospective chart review study, which found that antipyretic
premedication reduces the overall incidence of fevers for adult patients. However, this study also
conducted a cost-benefit analysis of the use of premedication considering factors like the cost for
stocking, ordering, supplying and administering a drug and the cost for health care professionals’
time (Ezidiegwu et al., 2004). The results of the analysis showed that the use of premedication
does not yield significant cost benefits for health care professionals and their institutions
(Ezidiegwu et al., 2004). Conservative estimates suggest that using acetaminophen and
diphenhydramine as premedication costs a health care institution more than 700 hours of nursing
time and 800 hours of pharmacist time, as well as more than $40,000 in drug administration
within one year (Sanders et al., 2005).
Despite current best evidence showing the lack of efficacy and cost-effectiveness of
premedication, routine premedication remains a common clinical practice to prevent TRs. As a
result, patients are exposed to potential adverse effects of premedication with no known benefits
(Christensen et al., 2019). Therefore, many researchers in the transfusion field suggest that
premedication should not be encouraged in the absence of definitive evidence-based studies
(Marti-Carvajal et al., 2010; Sanders et al., 2005; Tobian, King, & Ness, 2007).

11

2.3 Hemovigilance and TR Reporting
Hemovigilance is a system of surveillance procedures covering the entire transfusion chain from
the collection to the transfusion of blood components (De Vries, Faber, & Strengers, 2011).
Hemovigilance is designed to collect and assess information on undesirable effects resulting
from transfusions and to prevent their occurrence and re-occurrence (McClelland, Love, Scott, &
Williamson, 1998).
Hemovigilance systems consist of two levels. The first level comprises of blood establishments
and hospital blood banks. A blood establishment is a structure or body in charge of all aspects of
the collection, testing, processing, storage, and distribution of human blood and blood
components for transfusion and other purposes (e.g. Canadian Blood Services) (De Vries et al.,
2011). A hospital blood bank is a hospital unit that stores, distributes and perform tests on blood
and blood components exclusively for the use within this hospital (e.g. TMLs of Canadian
hospitals) (De Vries et al., 2011). The reporting of TRs at the local level is a fundamental
component of hemovigilance, which allows complete investigation of TRs, prevents future TR
re-occurrence, and assists the identification of risks present in blood donors and/or blood
manufacturing processes (Hussain et al., 2015).
The second level of hemovigilance exists at a regional, national and international level, which
adds value next to local systems in improving the safety of transfusions (De Vries et al., 2011).
The implementation of national-level hemovigilance varies globally. The first hemovigilance
system was established in Japan in 1993 (Juji et al., 2009). In the 1990s, Europe was also among
the pioneers to build the European vigilance network that connects multiple hemovigilance
systems, including France’s robust hemovigilance system in which reporting of all transfusion
incidents is a legal obligation (Debeir et al., 1999). In the United Kingdom, health care
institutions voluntarily report only serious TRs and incidents caused by human errors (e.g.
transfusions of wrong blood components) to their national surveillance system called Serious
Hazards of Transfusion (Bolton-Maggs & Cohen, 2013). In the United States, the
implementation of a national hemovigilance system is incomplete; morbidity and mortality
associated with transfusions are reported to multiple governmental, professional, and non-profit
regulatory agencies (Menitove, 1998; Whitaker, Belov, & Anderson, 2019). Hemovigilance also
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exists in some developing countries. For example, initiatives have been taken in African
countries like Zimbabwe and Uganda and Asian countries like China and India to improve their
hemovigilance systems (Faber, 2004).
Similar to the voluntary reporting system in the United Kingdom, Canada implemented a
national hemovigilance system in 2001, known as the Transfusion Transmitted Injuries
Surveillance System (TTISS). The TTISS aims to develop a comprehensive program for
reporting adverse transfusion events and reactions in Canada (Duncan, 2018). As of 2007, all
provinces and the Northwest and Yukon territories participate in the TTISS (Government of
Canada [GOC], 2014). The participation rate of hospitals in each of these provinces and
territories has increased gradually over time. By 2010, the participation rate was between 80%
and 100% in 11 provinces and territories, with only one province’s rate being less than 50%
(GOC, 2014). Ontario, being the largest user of blood components, accounts for 35% of all
transfusion activities in Canada (Duncan, 2018). Currently, 123 Ontario hospitals participate in
the Ontario Transfusion Transmitted Injuries Surveillance System (TTISS-ON), a provincial
division of the national TTISS (Duncan, 2018). Participating hospitals capture over 94% of the
transfusion activities in Ontario (Duncan, 2018).
Although minor TRs like fevers and MARs are not captured by the national hemovigilance
system, Ontario reports these minor TRs using a sentinel site model (Duncan, 2018). Sentinel
sites are a number of Ontario hospitals that capture and report all TRs, enabling TTISS-ON to
understand the total burden of TRs from minor to severe (Duncan, 2018). Between 2013 and
2017, Ontario sentinel sites reported a total of 2,445 TRs to transfused blood components and
plasma derivatives (Duncan, 2018). 20% of the reported TRs were classified as moderate to
severe, and 80% were minor TRs being captured through the sentinel site model (Duncan, 2018).
The studied institution voluntarily participates in the TTISS-ON as a sentinel site that reports all
TRs. According to the institutional practice guideline, each time a TR happens, the clinical team
in charge of the reacting patient should complete a TR report form and submit it to the TML
(LHSC & SJHCL, 2005). Currently, this institution utilizes a paper-based TR reporting system.
The TR report form should be ordered online from the electronic medical record (EMR) system
of the institution. The TR report form requires information including the date and time of the TR
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occurrence, the type of blood product transfused, the patient’s vital signs before transfusion and
at the time of the TR, the symptoms, and the interventions done by the clinical team. The form
automatically prints off following the online order. Then, the clinical team should manually fill
the form and fax it to the TML. Upon receipt of the TR report form, the TML recommends
testing, makes a diagnosis, or recommends interventions for the patient’s future transfusions.
Furthermore, a Transfusion Safety Officer at the TML will report the TR to the TTISS-ON.
Although the expectation of reporting all TRs is stated on the institutional practice guideline, the
TR reporting practices at this institution and health care professionals’ compliance with the
guideline have not been assessed previously. Neither are health care professionals’ perspectives
on TR reporting understood.
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Chapter 3

3

Methodology and Methods

This chapter describes the methodology and methods used in conducting this study. This chapter
begins by describing the study design, including the qualitative description approach and the
researchers’ philosophical assumptions. Then, the sample and sampling methods are discussed,
followed by a description of the data collection and data analysis processes. Furthermore, the
author’s reflexivity throughout the research process and the quality and ethical considerations of
this study are discussed.

3.1 Study Design
Qualitative Description
This qualitative study conducted a needs assessment and a barriers assessment at the studied
institution as part of the KT project (Graham et al., 2006). This study was conducted using a
qualitative description study design. Qualitative description is widely used in qualitative research
that is descriptive in nature, particularly in research that studies health care and nursing-related
phenomena (Kim, Sefcik, & Bradway, 2017).
Qualitative description differs from other qualitative approaches, in that it does not aim for
theory development as grounded theory, complex description of the group culture as
ethnography, nor interpretative meanings of lived experiences as phenomenology (Creswell,
2013; Neergaard, Olesen, Andersen, & Sondergaard, 2009). As a less interpretive approach,
qualitative description focuses on a journalistic account of the who, what, when, where, and why
of experiences and does not require a conceptual or highly abstract rendering of data, compared
to other qualitative approaches (Chafe, 2017; Neergaard et al., 2009; Sandelowski, 2000).
Although qualitative description is sometimes considered a less sophisticated form of inquiry
than the well-established qualitative approaches like grounded theory, ethnography, and
phenomenology, a number of researchers believe that qualitative description is a viable and
valuable qualitative research design (Bradshaw, Atkinson, & Doody, 2017; Chafe, 2017; Kim et
al., 2017; Sandelowski, 2000). Qualitative description is a powerful approach for health services
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and policy research that intends to bring about quality improvement, rather than to develop
conceptual understandings or theories of social phenomena (Chafe, 2017). Qualitative
description encourages change by keeping data analysis at an inference level where stakeholders
are readily able to understand, relate to and act upon (Chafe, 2017; Sandelowski, 2000). The end
product of a qualitative description study is a comprehensive descriptive summary of accurate
details of the data collected, in a language similar to participants’ and stakeholders’ everyday
language (Neergaard et al., 2009). For example, many qualitative description studies in the
nursing literature have sought to understand people’s barriers to health care, to health-promoting
activities, and to compliance with a medical regimen. Therefore, qualitative description was an
appropriate and effective approach for this study which aimed to understand the nursing
practices and perspectives of premedication and TR reporting and to assess the barriers and
facilitators to reducing premedication and improving TR reporting practices at the studied
institution.

Philosophical Assumptions
A systematic review on characteristics of qualitative description research found that most
reviewed studies did not specify their theoretical or philosophical framework (Kim et al., 2017).
Kim et al. (2017) suggest that qualitative description researchers should clarify their
philosophical assumptions to enhance the transparency and the rigor of their studies. As
researchers, philosophical assumptions are deeply rooted in our scholarly training. These
assumptions shape our research interest, the way we formulate our research questions, and the
way we seek answers to these questions (Huff, 2008). Articulating the philosophical assumptions
underlying a qualitative study will help reviewers understand the choice of research approach
and findings, allowing them to evaluate the quality of the study (Creswell, 2013; Kim et al.,
2017). Therefore, the philosophical assumptions underlying this study will be explained in the
following paragraphs.
Paradigmatically, this study lay within the constructivist paradigm. In constructivism, the goal of
research is to understand the varied and multiple lived experiences of individuals and to respect
their values and perspectives (Carpenter & Suto, 2008; Creswell, 2013). Aligned with the
constructivist paradigm, this study relied on participants’ narratives and views to understand
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current premedication and TR reporting practices and to identify barriers and facilitators to
practice change at the studied institution.
Ontologically, constructivists hold a relativist position and believe in multiple realities that are
constructed through individuals’ lived experiences (Guba & Lincoln, 1994; Ponterotto, 2005).
Subjective meanings of individuals’ experiences are formed through interaction with others and
through historical and cultural norms that operate in individuals’ social world (Creswell, 2013).
Similarly, in this study, the researchers believed that the nursing practices and perspectives of
premedication and TR reporting are socially constructed by and negotiated among the health care
professionals and other stakeholders who work at this institution.
Epistemologically, constructivist researchers attempt to get close to the participants being studied
(Creswell, 2013). Subjective evidence is assembled based on individual views (Guba & Lincoln,
1994). Knowledge is constructed through subjective experiences of participants and the
interaction between researchers and participants (Creswell, 2013; Guba & Lincoln, 1994).
Methodologically, this study followed an inductive, emerging and bottom-up logic, rather than
working top-down from the perspectives of the researchers. This means that the researchers did
not have expected answers in mind when they formulated the research questions and designed
the study. The interviewer was open-minded when interviewing participants. As themes emerged
during the data collection period, the interview guide and data collection strategy were modified
to reflect the increasingly detailed knowledge about the topics being studied (Creswell, 2013). It
is important to note that using an inductive method does not mean the values and beliefs of the
researchers are disregarded. Constructivism values not only participants’ experiences of the
phenomenon of interest, but researchers’ interpretations and understanding (Guba & Lincoln,
1994; Ritchie, Lewis, McNaughton Nicholls, & Ormston, 2014). Accordingly, the researchers
brought to the inquiry a certain paradigm, perspective, and a “basic set of beliefs that guides
action” (Guba, 1990).
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3.2 Sample and Sampling Methods
Purposeful Sampling
Purposeful sampling is an approach in qualitative research that identifies and selects informationrich cases to study a phenomenon of interest (Patton, 2002). In line with the goal of qualitative
research to achieve the depth of understanding, studying information-rich cases allows one to gain
an in-depth understanding about central issues of the research problem rather than making
quantitative generalizations (Palinkas et al., 2015; Suri, 2011).
According to Creswell (2013), three aspects should be considered when using the purposeful
sampling approach: 1) whom to select as participants (or sites); 2) the type of sampling strategy;
and 3) the size of the sample.

Participants in the Sample
Purposeful sampling involves identifying and selecting individuals who are experienced with or
knowledgeable about the phenomenon being studied (Creswell, 2013; Palinkas et al., 2015). The
goal of this study was to understand the nursing practices and perspectives of premedication and
TR reporting at the studied institution, where the researchers hoped to bring about practice
change. Thus, the researchers chose to interview nurses from the adult oncology inpatient unit
and the adult oncology outpatient unit at this institution.
Nurses were the targeted population because they are frontline health care professionals who
directly administer transfusions and deal with all aspects of transfusions. When TRs happen,
nurses are the first persons who notice the symptoms. They are the ones who notify physicians
about TRs and report to the TML. They also take a major responsibility in managing and treating
TR symptoms. As such, nurses are the most involved health care professionals in the TR
management and reporting process. Physicians are also involved in the TR management process
by ordering premedication and treatments and providing instructions to nurses. But in general,
physicians are less involved than nurses, as they mainly provide supporting and supervising
roles. Physicians also infrequently get involved in the process of reporting TRs to the TML. In
addition, compared to nurses who are the longitudinal staff in hospital units, physicians tend to
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rotate and therefore, are less familiar with TR reporting procedures in the selected units. Due to
the considerations discussed above, this study focused on the nursing practices and perspectives
in order to optimize the rigor and relevance of the data collected.
The adult oncology inpatient unit is where adult cancer patients receive treatments during their
hospital admissions. Treatments include chemotherapy, antibiotics, and other supportive care
such as blood transfusions. Chemotherapy affects blood cell production, so blood transfusion is
an integral part of oncology care and a common treatment at the adult oncology inpatient unit.
The adult oncology outpatient unit administers treatments to adult cancer patients who are well
enough to receive therapy in a day clinic without hospital admissions. Blood transfusions are
administered frequently here to ensure patients remain well after chemotherapy treatments and to
avoid hospital admissions. Patients in the adult oncology outpatient unit are generally less ill
and have less severe infections and fevers compared to patients in the adult oncology inpatient
unit. If patients develop a fever during a blood transfusion, they may require hospital admissions
for investigation and treatments; so prevention of fevers in the adult oncology outpatient unit is
desirable.
The adult oncology inpatient unit and the adult oncology outpatient unit were selected for three
reasons. Firstly, based on the records from the TML, these two units administer a large number
of transfusions. Thus, nurses from these units are more likely to be “information-rich” because
they are more experienced with transfusions (Patton, 2002). Secondly, these units are identified
as the best “microsystems” of the KT project (Agency for Healthcare Research and Quality
[AHRQ], 2017). Microsystems in health care organizations refer to small units of caregivers,
administrative and other staff who deliver care and services on a daily basis (AHRQ, 2017).
More specifically, for this KT project, microsystems are hospital units with the same clinical
aims and shared performance outcomes (AHRQ, 2017). AHRQ (2017) recommends a quality
improvement plan to select best microsystems to test new ideas before scaling interventions to
the broader organization. Again, since the adult oncology inpatient and outpatient units are one
of the most frequently transfusing sites, they were identified as the best microsystems to conduct
needs and barriers assessment and to implement change. Thirdly, a recent study examining TR
reporting patterns of care providers showed that adult providers reported more non-transfusionrelated reactions than paediatric providers, suggesting a poorer ability to recognize true TR

19

reactions by adult providers (Vossoughi et al., 2019). Therefore, the researchers decided to target
adult units as the pilot group of the KT project.

Sampling Strategy
Criterion sampling is a purposeful sampling strategy to identify and select participants that meet
some predetermined criterion of importance (Miles, Huberman, & Saldana, 2014; Palinkas et al.,
2015). It is the most commonly used sampling strategy in KT research and useful for quality
improvement (Miles et al., 2014; Palinkas et al., 2015). The inclusion criteria of this study are: 1)
registered nurses; 2) work in either the adult oncology inpatient unit or the adult oncology
outpatient unit at the studied institution; and 3) have administered at least one transfusion.
Individuals who did not fulfill these criteria were not eligible to participate in the study.
The recruiting process started by gaining approval from the nursing coordinators of the two units
to conduct interviews at their units. A week prior to interviews, the nursing coordinators sent a
Letter of Information (see Appendix B) that fully disclosed the study’s objectives and procedures
to all nurses in their respective units. Then, on the days of interviews, the interviewer went to the
units, approached nurses and briefly explained the study and the inclusion criteria. For
individuals that met the inclusion criteria, the interviewer asked for their willingness to
participate in the study and obtained verbal informed consents from those who agreed. For
individuals who did not consent to participate in the study, their decisions were respected.

Sample Size
The goal of qualitative research is to elucidate a specific phenomenon, rather than to generalize
the study findings or to gain external validity (Creswell, 2013). Therefore, a general guideline for
sample size in qualitative studies is to collect extensive details about the site or individuals of
interest (Creswell, 2013). In this study, sample size was not predetermined prior to data
collection. Instead, interviews were conducted until saturation was reached. According to Grady
(1998, p. 26), “New data tend to be redundant of data already collected. In interviews, when the
researcher begins to hear the same comments again and again, data saturation is being reached”.
As the only researcher conducting interviews, the author was familiar with the interview content.
After hearing similar information over and over again in the interviews, the author was confident
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that “informational redundancy” and data saturation occurred (Guest, Bunce, & Johnson, 2006;
Sandelowski, 2008). Furthermore, as data collection and data analysis took place simultaneously,
the author decided to stop sampling when she noticed that no new codes or themes emerged from
additional data, which also suggested data saturation (Given, 2016).

3.3 Data Collection
This study utilized primary data source, which were collected by conducting one-to-one semistructured interviews with nurses who administer transfusions in the adult oncology inpatient
unit and the adult oncology outpatient unit at the studied institution. The purpose of interviews
was to understand the current premedication and TR reporting practices in the two units, to
assess the need for practice change, and to identify barriers and facilitators to practice change.
To achieve the optimum use of interview time in qualitative research, interview guides are often
used to keep interviews focused on the desired line of action and to explore participants’
experiences more systematically and comprehensively (Dicicco-Bloom & Crabtree, 2006). In
qualitative description research, interview guides are typically based on expert knowledge to
focus on areas that are poorly understood in a health care setting and potentially amenable to
change and interventions (Neergaard et al., 2009). For this study, a semi-structured interview
guide (Appendix C) was developed in discussion with the author’s thesis committee. The
interview guide was a schematic presentation of ten questions with probing sub-questions that
were related to the central research questions of this study (Dicicco-Bloom & Crabtree, 2006).
The interviews were conducted during a one-month period from November 2018 to December
2018. Interviews took place in the respective units where participants worked. Each interview
lasted approximately ten minutes. The participants were audio-recorded by a professional digital
audio recorder during the interviews unless they chose to opt out of audio recording. For those
who opted out, their responses were written down manually and included in data analysis.
Data analysis took place at the same time as data collection. As themes emerged during data
analysis, the interview guide was modified and transformed to further explore emerging issues
and themes. Reflexive field notes were written during and after each interview to keep track of
the author’s experiences in the field, observation and reflection, and her ongoing and developing
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understanding, analysis and interpretation (Creswell, 2013). Data collection ended when
saturation was reached (Given, 2016; Grady, 1998).

3.4 Data Analysis
Data Transcription
Interviews were transcribed verbatim by a professional transcription company. By reading,
correcting and clearing the interview transcripts while playing the original audio files, the author
ensured the accuracy and confidentiality of the transcripts’ content.
Two participants from the adult oncology outpatient units refused to be audio-recorded, so audio
files or transcripts were not available for their interviews. Instead, the author wrote down their
responses in her field notes while conducting the interviews. On the same day after the
interviews, the author formulated their responses based on her field notes and memory. Their
responses were included in the data analysis.

Thematic Analysis
Transcripts were thematically coded and analyzed, guided by Clarke and Braun’s (2012) thematic
analysis (TA) method. TA is an appropriate method because it aims for a rich description of the
data set and is especially useful for an under-researched area with participants’ views unknown
(Vaismoradi, Turunen, & Bondas, 2013). Researchers using TA do not subscribe to any implicit
theoretical commitments, which is also in line with the qualitative description design of this study
(Clarke & Braun, 2012).
A semantic-level TA was conducted by taking the face value of data and not going too conceptual
or theoretical (Vaismoradi et al., 2013). This allows participants and stakeholders from the studied
institution to understand and relate to the results.
Furthermore, the study utilized an inductive and data-driven TA approach with an assumption of
a knowable world and a commitment to give voice to experiences and meanings of that world
(Clarke & Braun, 2012). It is important to acknowledge that being purely inductive in research is
impossible, as researchers always bring their epistemological beliefs and inseparable positionality
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to edata when they collect and analyze them (Fox, 2004). However, as Clarke and Braun (2012)
said, “consistency and coherence of the overall framework and analysis are what is important” (p.
59).

Analysis Process
Data analysis was an iterative process and began at the time of data collection (Creswell, 2013;
Glaser, Strauss, & Strutzel, 1967). According to Clarke and Braun (2012), TA is a six-phase
approach. During phase 1, researchers familiarize themselves with the data (Clarke & Braun,
2012). Since the author collected all the data, she was confident in her familiarity with the data.
To further immerse herself in the data, she read and reread transcripts and listened to audio
recordings (Clarke & Braun, 2012).
Phase 2 involves the systematic analysis of the data through coding (Clarke & Braun, 2012). In
this study, the coding process started as soon as transcripts of early interviews became available.
The author coded the transcripts by writing down brief descriptions of what were being discussed
in the interviews (Creswell, 2013). Transcripts from the two units were first coded
independently. Coding helped the author organize the data into meaningful groups, which later
on emerged into preliminary themes.
In phase 3, data analysis starts to take shape as researchers begin to search for themes (Clarke &
Braun, 2012). The author brought together codes from two different units in constant
comparative analysis, adopted from Glaser et al.’s (1967) grounded theory. Constant
comparative analysis was used to explore similarities and differentials at both individual
participant and unit levels and to search for prominent themes (Glaser et al., 1967).
Phase 4 involves a recursive process of reviewing potential themes (Clarke & Braun, 2012).
Preliminary themes were tested on further rounds of data for verification or rejection, as more
data were being collected, coded and analyzed (Creswell, 2013; Glaser et al., 1967). Developing
themes were reviewed in relation to coded data and the entire data set. Some codes were
discarded or relocated under another theme. Some themes’ boundaries were redrawn so that they
captured the relevant data more meaningfully. The author then performed a final reread of the
entire data set to ensure that she had a set of themes that captured the most important and

23

relevant elements of the data in relation to the research questions (Clarke & Braun, 2012).
Throughout this phase of TA, cleaned interview transcripts (names, units and other identifiers
removed) and coding schemes were shared and discussed with the author’s thesis committee.
The committee members provided feedback and alternative interpretation of the data after they
read the transcripts and coding schemes created by the author. After a few rounds of discussions
and edits, the results presented in themes in Chapter 4 were based on mutual agreement between
the author and the thesis committee. The engagement of the thesis committee in data analysis
added triangulation, multivocality and hence credibility to this study (Tracy, 2010).
During phase 5, researchers define and name themes (Clarke & Braun, 2012). In this study,
themes were defined and named to clearly state the unique and specific aspect about each theme.
The researchers ensured that the themes 1) had a clear focus, scope and purpose; 2) were related
but not overlapping; and 3) directly addressed the research questions (Clarke & Braun, 2012).
The defining and naming phase was also conducted with the involvement of the thesis
committee.
Lastly, phase 6 is the production of a report (Clarke & Braun, 2012). In qualitative research,
reporting writing is not a phase that only begins at the end (Clarke & Braun, 2012). In this study,
writing and analysis were interwoven—from informal writing of field notes and reflexive
journals to the formal process of thesis writing. Throughout the thesis writing process, drafts
were shared with the author’s thesis committee, friends and family to ensure the production of an
accurate, comprehensive and readable thesis.

3.5 Reflexivity
It is neither warranted or realistic for a researcher to enter a field without any preconceived ideas
of what one may expect to find, aspiring to fulfill a purist conception of scientific objectivity and
impartiality (Fox, 2004). In fact, in this study, researchers’ perspectives, experiences and
assumptions were recognized because the meanings of participants’ experiences and perspectives
were believed to be co-constructed only through interactive researcher-participant dialogue and
interpretation (Ponterotto, 2005).
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Prior to the participation in this KT project, the author learned some basic knowledge about
blood in a physiology course during her undergraduate education. However, the author did not
have any background in the clinical aspects of blood transfusion. The author gained knowledge
about transfusion practices, premedication and TR reporting by reading relevant literature and a
blood administration handbook that all nurses at this institution own and refer to (Lima, 2015).
Throughout the research process, the author also actively communicated with her thesis
supervisor, who is a hematologist and a transfusion medicine specialist at this institution, and
with a Transfusion Safety Officer, who is a senior nurse in charge of TR management and
reporting at this institution. Prior to collecting data, the author learned from their observations
that health care professionals at this institution inconsistently report TRs to the TML. Therefore,
the author’s interaction with participants and her interpretation of participants’ experiences and
perspectives might be influenced by the anticipation of poor TR reporting behaviours.
Moreover, with no background in blood transfusion and no experience working at this
institution, the author identified herself as an “outsider” researcher entering a new field (Finlay,
2002; Minkler, 2004). The author considered her outsider identity as an advantage because it
allowed her to keep an open mind and see things from different angles than people working at
this institution. When the author interviewed participants, she sensed some imbalanced power
relations between her, a novice researcher and an outsider of the institution, and the participants,
who were insiders with experience and clinical expertise in transfusions. Despite the researcherresearched power imbalance, the author’s role and position in the research were not passive and
did not impart a disadvantage to this study. Instead, as a novice researcher, the author’s curiosity
and humility helped leverage in-depth investigation of the participants’ experiences and
perspectives.

3.6 Criteria of Quality
Maintaining quality is an essential aspect of qualitative research. The quality of this study was
established by employing Tracy’s (2010) “big-tent” criteria for evaluating qualitative research.
This study focused on a “worthy topic” that was relevant, timely, significant and interesting
(Tracy, 2010). Our focus on evidence-based premedication and TR reporting practices was
counterintuitive as it questioned taken-for-granted assumptions on premedication and challenged
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well-accepted practices at this institution (Tracy, 2010). Exploring little-known nursing
perspectives on premedication and TR reporting was intrinsically interesting and meaningful
(Tracy, 2010). “Rich rigor” was established by making smart choices about sample and contexts
(Section 3.2), collecting abundant data (Section 3.3), and providing a thorough explanation of the
data analysis process (Section 3.4.3) (Tracy, 2010). “Sincerity” was achieved through selfreflexivity by focusing on the researchers’ subjective experiences, hopes, expectations, and
vulnerabilities (Section 3.5) (Tracy, 2010). The author was the primary data collector and
analyzer. Therefore, she was able to have significant interaction with participants, be familiar
with the data and the context, and incorporate reflexivity throughout the research process
(Finlay, 2002). Another practice of “sincerity”, transparency, was demonstrated by being honest
about the research process and providing a methodologically self-critical account of how the
research was done (Tracy, 2010). “Credibility” of this study was enhanced by adhering to the
research questions and focusing on a thick descriptive account of participants’ practices and
perspectives (Tracy, 2010). The themes were reviewed and discussed by multiple analysists to
develop multiple interpretations of the data, which added triangulation to the study (Patton,
1999; Tracy, 2010).

3.7 Ethical Considerations
A research ethics application (project ID: 112275) was submitted to Western University’s
Research Ethics Boards, which manages the approval and monitoring process for human
research at the university and its affiliated hospitals and research institutes, including the studied
institution. Upon preliminary review, this study was granted an exemption from the review of
Western’s Research Ethics Boards because it fell under the definition of quality improvement
(see Appendix D for REB Waiver).
Beauchamp and Childress’ (2009) four principles of biomedical ethics—respect for autonomy,
beneficence, non-maleficence and justice—are now routinely applied to health research as the
basis for ethical research design and conduct (Watts, 2011). The concepts of vulnerability and
respect for autonomy are important in health research to ensure that research participants are
protected from harm and distress, and that they are fully informed and freely consenting
participants (Watts, 2011). Participants of this study were nurses, who are not considered as
vulnerable in the context of health research. Nevertheless, this study was designed to ensure that

26

no anticipated risks or harm were associated with participating in the study. Participants may not
directly benefit from participating in this study, but information gathered may improve the
understanding of current transfusion practices, provide guidance to the implementation of
evidence-based transfusion practices, and benefit patients by providing safer and more efficient
patient care at the institution. A Letter of Information (Appendix B) that fully disclosed the
study’s objectives and procedures was sent to potential participants prior to interviews. Verbal
informed consents to participate in the study were obtained, and participants were made aware of
their right to withdraw from the study at any time.
Privacy and confidentiality are also essential for conducting ethical health research. The study
aimed to learn about general practices and perspectives rather than identifying individual
participants or their patients or colleagues. The interview guide was carefully designed to collect
only the necessary information, and minimal demographical data were collected. Any
information mentioned during interviews that might act as an identifier was cleared out in
transcripts. Participants’ confidentiality was preserved, and individual responses were not shared
with their colleagues or supervisors.
An ongoing debate in qualitative research is on whether values of researchers or participants
should guide the direction of research (Creswell, 2013; Guba & Lincoln, 1994). Here, the notions
of self and reflexivity come into play. Watts (2011) highlights the ethical significance of
reflexivity as a way for the researcher to maintain an ongoing ethically engaged presence in the
field. The researcher needs to identify oneself, understand and be transparent about theoretical,
epistemological and personal assumptions that they brings into the research (Watt, 2011).
Relevant discussions on reflexivity and philosophical assumptions can be found in Section 3.5
and 3.1.2.
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Chapter 4

4

Results

This chapter presents the results of this study. First, participant characteristics are described.
Then, the results are presented in themes in two sections. The first section describes the
institutional practices of administering premedication and participants’ perspectives on
premedication. The second section describes the nursing practices of TR reporting and
participants’ perceived barriers and facilitators to improving TR reporting practices.

4.1 Participant Characteristics
Twenty-five participants were interviewed for this study. All participants are registered nurses
who work at the studied institution. Fifteen participants (I1 to I15) work in the adult oncology
inpatient unit. Ten participants (O1 to O10) work in the adult oncology outpatient unit. Relevant
demographic information about participants is displayed in Table 1. Other demographic
information such as gender and age of participants is not considered as an influencing factor for
this study. Therefore, such information was not reported for privacy protection.
Table 1 Participants' Demographic Information
Participant
#

I1

I2

I3

Occupation

Registered
nurse

Registered
nurse

Registered
nurse

Unit

Participant
#

Adult
oncology

I14

inpatient
Adult
oncology

I15

inpatient
Adult
oncology
inpatient

O1

Occupation

Registered
nurse

Registered
nurse

Registered
nurse

Unit
Adult
oncology
inpatient
Adult
oncology
inpatient
Adult
oncology
outpatient
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I4

I5

I6

I7

I8

I9

I10

I11

I12

I13

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Adult
oncology

O2

inpatient
Adult
oncology

O3

inpatient
Adult
oncology

O4

inpatient
Adult
oncology

O5

inpatient
Adult
oncology

O6

inpatient
Adult
oncology

O7

inpatient
Adult
oncology

O8

inpatient
Adult
oncology

O9

inpatient
Adult
oncology
inpatient
Adult
oncology
inpatient

O10

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Registered
nurse

Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
Adult
oncology
outpatient
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4.2 Premedication
This section describes the institutional practices of administering premedication and participants’
perspectives on premedication. Results were derived from the data of both units. Three major
themes about premedication emerged from the data: 1) the roles of different health care
professionals; 2) factors impacting the decision to premedicate; and 3) nurses’ perspectives on
premedication.

Roles of Different Health Care Professionals
All participants described the roles of different health care professionals in the use of
premedication. Specifically, two groups of health care professionals are involved in the practice
of premedicating patients before their transfusions: 1) physicians, residents, and nurse
practitioners; and 2) nurses.
All participants mentioned that physicians, residents and nurse practitioners, altogether termed as
“the prescribers”, are the health care professionals that have privileges to prescribe
premedication. One participant explained that “We have physicians, nurse practitioners as well
as residents following [patients that receive transfusions]. So whoever are following them for the
day […]” decide whether or not to premedicate patients prior to their transfusions (I12). This
participant also added that “sometimes [the prescriber] will consult the [hematologist or
oncologist in charge] of the week” before making the decision to premedicate patients (I12). In
cases where premedication is considered necessary, the prescriber would order premedication
through the EMR.
Regarding the roles of nurses, many participants explained that nurses notice symptoms of suspected
TRs during transfusions and notify the prescriber about the symptoms. For example, one participant
described the process: “We check the patient’s vitals and if there are any signs or symptoms, then
we page [the prescriber] and let them know” (I13). Nurses also document the symptoms on the EMR
so that this information is available online for everyone who has access to patient records. Nurses
do not have the authority to prescribe premedication. Therefore, as one participant said: “We have
to tell [the prescriber] about the symptoms and see what they want to do” (I11). In cases where the
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prescriber adds premedication to the patients’ regimens, nurses give premedication according to the
prescriber’s orders, which are indicated on the EMR.

Factors Impacting the Decision to Premedicate
During the interviews, participants mentioned five factors that impact the clinical decision of
whether or not to premedicate a patient. The most predominantly reported factor was the
patient’s transfusion history. Other factors included: 1) the prescriber’s clinical judgment; 2) the
nurse’s advocacy for premedication; 3) the TML’s recommendations; and 4) the patient’s
knowledge about their transfusion history.

4.2.2.1

Patient’s Transfusion History

The most predominantly reported factor that influences the decision to premedicate was a
patient’s transfusion history. Firstly, whether or not the patient has a history of TRs impacts the
decision to premedicate. Many participants stated that premedication is a common practice for
patients who have previous TRs. A few participants emphasized that premedication is not a
universal treatment for everyone who receives transfusions; it is only common for patients with a
history of TRs. As one participant explained, “We don’t normally give premedication
anticipating a reaction on someone who has never had a reaction with [transfusions]. There is no
point giving it to everyone” (O1). A couple of participants stated that patients need to have
repeated TRs before they are premedicated. For example, one participant said that “normally,
patients have to have two of the same reactions before we premedicate them […] If the first one
was a fluke or if there was a secondary external cause, then [the prescriber] would decide, if [the
patient] had a fever they’d premedicate with [acetaminophen] or if [the patient] had hives they
could premedicate with [diphenhydramine]” (I12).
Secondly, the type of past TRs influences the decision to premedicate. On the one hand,
participants discussed several past symptoms that often lead to premedication in future
transfusions. According to participant I9, “generally, [prescribers] are pretty good about ordering
premedication when [patients] got hives.” Similarly, participant O3 confirmed that patients who
have experienced MARs and shortness of breath during their past transfusions “would definitely
be premedicated” for their future transfusions. Participant O1 added that “sometimes patients will
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be prescribed [furosemide] […] if they have a cardiac history and we’re worried about fluid
overload … [furosemide] helps flush that out”. On the other hand, patients who developed fevers
during their past transfusions are not consistently premedicated for their future transfusions. A few
participants stated that prescribers would normally not premedicate patients with previous febrile
reactions. One reason for not premedicating previously febrile patients, according to one
participant, is the perception that “fevers are not necessarily related to transfusions” (O1). This
participant further explained that “sometimes someone might spike a temperature that we were
kind of anticipating because they’ve been febrile the whole time” (O1). Many other participants
confirmed that some patients are regularly febrile during their stay in the hospital and may go into
transfusions with pre-existing fevers. One participant shared their interpretation of why prescribers
may not premedicate previously febrile patients:
Sometimes [prescribers] may think it’s not a reaction. They think that with all the stem cell
stuff, [patients] are always spiking fevers randomly. And they think maybe with their counts
being so low […] it’s more just that they’re spiking a regular fever, not due to the blood. So
the one time that I saw a patient [spiked a fever] […] [the patient] received platelets after
and I don’t think she was premedicated for that. (I14)
Contrarily, another participant disclosed that even though some fevers are not considered
transfusion-related, “sometimes [prescribers] will say ‘You know what, we’ll give
[acetaminophen] [as a premedication]’” (O1). Few other participants also described fevers as a
symptom that commonly gets premedication.
Thirdly, several participants considered the severity of past TRs an influencing factor. For
instance, one participant said that the practice of premedicating patients is “not very often unless
they have an extremely bad reaction” (I11). Another participant also shared a similar
observation: “If [patients] have had a significant reaction, then usually we are seeing some
[diphenhydramine], [acetaminophen] and hydrocortisone for our [regularly transfused] patients”
(O7).
Lastly, one participant mentioned that the type of blood product being administered also impacts
the decision to premedicate. The participant described a situation where “one patient had a
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reaction to platelets … then every transfusion of platelets after, we gave [diphenhydramine]
beforehand. But with her blood cells [transfusions] we didn’t [premedicate]. So it depends on
which products [are administered]” (I11).
In summary, the most predominantly reported factor that influences the decision on
premedication was the patient’s transfusion history, including the existence of past TR history,
the type of past TRs, the severity of past TRs, and the type of blood product being administered.

4.2.2.2

Other Factors Impacting the Decision to Premedicate

Besides the patient’s transfusion history, other factors impacting the decision of premedicating a
patient included: 1) the prescriber’s clinical judgment; 2) the nurse’s advocacy for
premedication; 3) the TML’s recommendations; and 4) the patient’s knowledge about their
transfusion history.
As discussed in Section 4.2.1, physicians, residents and nurse practitioners, known as “the
prescribers”, are the health care professionals who prescribe premedication to patients. All
participants considered the prescriber’s clinical judgment as a determining factor for the
premedication decision-making. One participant further explained that the decision to
premedicate may vary between different prescribers, and that such decision is based on the
prescriber’s preference (A17). This participant shared an example of conflicting opinions
between prescribers on what premedication should be prescribed to a patient:
I find sometimes [the decision to premedicate] depends on the physician versus [nurse
practitioner] versus resident […] the [premedication] orders will differ depending on their
preferences, which I feel like it could be more unified […] I had a patient once who literally
just had a fever reaction and [the physician] wanted me to give [diphenhydramine]. And then
the nurse practitioner who was following [the patient] for the day was like: “Why did we give
[diphenhydramine]? Like we should have just given him [acetaminophen].” I feel like [the
premedication practices] could be a bit more unified. (A17)
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Another factor that impacts the decision to premedicate is the nurse’s advocacy for
premedication. One participant shared their experience of holding different opinions from
prescribers on whether to premedicate certain patients:
The problem with our patients is that they’re often septic, so our [prescribers] will attribute
[symptoms during a transfusion] more to sepsis than as a transfusion reaction necessarily.
Sometimes it actually is a transfusion reaction and [the prescriber] just doesn’t end up
ordering [diphenhydramine] or [acetaminophen] until it happens again. (I9)
Therefore, this participant who sometimes holds different opinions on premedication from
prescribers’, would “prompt [premedication] to happen” when past symptoms were not followed
up on by prescribers (I9). Contrarily, another participant would intervene with the premedication
decision by not reporting minor TRs to prescribers. This participant explained that “You could
call the [prescriber], but if [the patient] just said they had a low-grade fever one time […] I
would just […] be comfortable enough to go ahead with the transfusion [without calling the
prescriber for premedication]” (O3). Other than participant I9 and O3, most participants did not
play an active role in the premedication decision-making. They stated that they would follow the
prescriber’s premedication orders and administer premedication accordingly.
Furthermore, the TML’s recommendations were considered a factor that impacts the
premedication decision. One participant suggested to further involve the TML in the TR
management process and explained that “if [the TML] recommends we do premedication for our
patients, that would prompt our nurses to go to [prescribers] and say: ‘[the TML] believes that
we need [premedication]’” (I9).
In addition, one participant reported using the patient’s knowledge of their transfusion history to
decide whether or not to premedicate (O3). This participant explained that some patients might
receive their previous transfusions at other hospitals; thus, their past TR history may not be
documented on the EMR of this institution. Therefore, this participant would ask the patient for
their past TR history before each transfusion. The information that the patient provides would be
factored into the premedication decision-making.
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Nurses’ Perspectives on Premedication
This section presents participants’ perspectives on premedication. Three sub-themes emerged
from the data: 1) belief in the efficacy of premedication; 2) perceived benefits of premedication;
and 3) perceived risks of premedication.

4.2.3.1

Belief in the Efficacy of Premedication

All participants believed that premedication effectively helps patients with a history of TRs by
preventing future TRs. When being asked about their reasons for believing in the efficacy of
premedication, many participants provided subjective rather than evidence-based answers, with
their responses being “I think so”, “I guess so”, and “I feel like […]”. For example, one
participant said: “I feel like it’s riskier not to [premedicate] than it is [to premedicate]” (I12).
A couple of participants supported their beliefs with anecdotal evidence, such as witnessing
patients not developing TRs after taking premedication. One participant referred to a patient who
“comes here twice a week for her transfusions […] her diagnosis is multiple myeloma, [she has]
reacted severely to platelets […] but with premedication [she] can tolerate and doesn’t have to go
to specific, single-donor platelets” (O7). Another participant also observed a patient who “comes
three times a week and she always gets premedicated […] she sometimes will get a little rash
with all the premedication […] but for the most part she tolerates it very well” (O2).
Only one participant showed awareness of alternative methods that the TML provides to prevent
TRs. This participant believed in the effectiveness of premedication while showing awareness that
“the [TML] will also provide irradiated blood … which is extra cleaned” as another effective method
to prevent TRs (I14).

4.2.3.2

Perceived Benefits of Premedication

While discussing their perspectives of premedication, participants mentioned three benefits of
premedication they perceived. Firstly, all participants believed that premedication helps prevent
TRs and associated risks during transfusions. For example, one participant said: “I think that
[premedication] helps because if there’s another reaction, it could be more severe than the
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previous one. So [premedicating the patient] is better for the patient and it’s also better for us
because there’s less risk of complications” (I15).
Secondly, a few participants believed that premedication provides emotional support to both
patients and health care professionals. “For those people who we know for sure get reactions”,
said one participant, “[premedication] gives both the patient and the staff a peace of mind that
[the TR] aspect has been looked after; if [the patient] still react [after being premedicated] then
maybe it has to be reassessed” (I8). Furthermore, another participant also believed that
premedication benefits patients emotionally, as “it certainly makes the [transfusion] experience
much more comfortable and […] far less scary for [patients] when they don’t have to
[experience] transfusion reaction” (O4).
Lastly, a couple of participants believed that using premedication increases the efficiency of
health care delivery by preventing TRs and shortening the transfusion time of patients. One
participant explained that “the patient is in and out quickly when there are no transfusion
reactions, so there’s a quicker turnaround time on the beds to get the next patient in” (O4).
Another participant held a similar view that patients “tolerate transfusions and get out of the
hospital quicker [with the help of premedication]” (O7).

4.2.3.3

Perceived Risks of Premedication

When being asked about the risks of premedication, most participants mentioned drowsiness, a
side effect of diphenhydramine. Drowsiness raised some concerns about the transportation issue
of patients getting diphenhydramine as premedication, because they are not allowed to drive
home by themselves after transfusions. One participant shared their concern: “Especially with
the elderly population routinely getting [transfusions], how are they travelling back and forth?”
(O7) Another participant explained that drowsiness can make elderly patients off balance and
more prone to falling, posting a safety concern on their health (O8). Other than the transportation
issue related to diphenhydramine, one participant explained that patients taking diphenhydramine
need to wait 45 minutes after finishing transfusions before they can leave the bed (O10). The
long wait time for discharge increases the bed turnaround time and decreases the efficiency of
care delivery. Other than the drowsiness caused by premedication, one participant stated that
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using premedication may suppress and mask a severe TR such as acute hemolysis and sepsis and
prevent appropriate care for the TR (O2).

Summary
Section 4.2 describes the institutional practices of administering premedication and participants’
perspectives on premedication. Three major themes about premedication emerged from the data:
1) the roles of different health care professionals; 2) factors that impact the premedication
decision; and 3) nurses’ perspectives on premedication.

4.3 Transfusion Reaction Reporting
This section presents the findings of TR reporting practices at the studied institution. All
participants agreed that nurses take a major responsibility in TR reporting. Participants stated
that most TR reports are completed by nurses. Physicians sometimes order TR report forms for
nurses, but nurses are the ones who fill and fax reports.
Three major themes emerged from the data: 1) factors impacting nurses’ TR reporting practices;
2) barriers to TR reporting; and 3) facilitators to TR reporting.

Factors Impacting Nurses’ TR Reporting Practices
During the interviews, participants were asked to describe the nursing practices of reporting TRs
to the TML. Four factors that impact participants’ TR reporting practices emerged from their
responses: 1) the type of TR; 2) the physician’s assessment; 3) the nurse’s own discretion; and 4)
the institutional TR diagnostic guideline.

4.3.1.1

Type of Transfusion Reaction

During the interviews, participants discussed how they would report the two most common types
of TRs: fevers and MARs. The practices of reporting fevers and reporting MARs were found to
be distinctly different.
In terms of reporting fevers, a majority of participants mentioned that if a fever is considered as
non-transfusion-related, it is usually not reported to the TML. According to many participants,
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fevers are usually not attributed to transfusions, but to patients’ pre-existing febrile conditions
and primary diagnoses. Many participants reported that a lot of patients are admitted with fevers
and are intermittently febrile during their stays at the hospital because of sepsis, infections and
low immunity due to cancer or transplants. Thus, as fevers are often considered as not
transfusion-related, they are often not reported to the TML as one participant described:
I do think that fevers aren’t always [reported] […] Sometimes, especially at [adult
oncology inpatient unit], people get fevers quite often and it isn’t always because of
transfusion reactions; it’s more so because of their primary diagnosis […] I don’t think in
those cases [fevers] really need to be reported. Especially if they’ve had previous fevers in
the day. (I15)
Furthermore, another participant expressed that “It’s okay that [a fever] is not reported because
every blood product you get has a different donor” (O3). Their rationale is that the patient who
had a fever during a transfusion episode would not necessarily react to a different donor’s blood
products in their next transfusion. One participant said: “I would just hope and trust the
judgement of the patient when you ask them—and we ask them every time they come in even if
[previous fevers] are not recorded on [the EMR]—we always ask them if they’ve had a reaction
before or if they’ve had any side effects” (O3).
On the contrary, MARs are often reported to the TML, according to most participants. Unlike
fevers that are usually pre-existing, MARs are rarely present prior to transfusions. Therefore,
when the patient develops a MAR during a transfusion, the symptom is often considered as
transfusion-related and reported. As one participant said: “I would report [MARs] […] clearly
they didn't have [MARs] before, and they're getting blood now […] that's blood-related” (O6).
In addition, one participant implied that the different practices of reporting fevers versus
reporting MARs are due to the different levels of severity: “If it’s a low-grade fever, not
necessarily […] but if it was a big reaction, that’s going to be reported […] if someone had
[MARs] and really itchy then we would […] definitely report” (O3).
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4.3.1.2

Physician’s Assessment

According to many participants, physicians are rarely directly involved in the TR reporting
process. However, other than a couple of participants who were completely unsure of the
reporting process due to the lack of reporting experience, most participants described that the
physician’s assessment of a suspected TR has an impact on their decision on whether to report
the TR. The levels of physicians’ impact can be displayed on a spectrum, where participants
being impacted the most lie on the lower end, and participants being impacted the least lie on the
higher end (as shown in Figure 1). Moving from left to right of the spectrum, participants rely
less and less on physicians’ assessments, and their independence of TR reporting increases.

Figure 2: The Spectrum of Physicians’ Impact on Participants’ TR Reporting Practices
A few participants stated that their decision on whether to report a TR is solely based on the
physician’s assessment. For instance, one participant described how they would decide whether to
report a TR:
I would be calling the physician […] Maybe it’s a decision to just monitor and see, but I would
[…] be looking at a physician to drive where that should go. Would I document it on the
[report] form? If the physician feels it's related to the transfusion, then, yes, I would. If the
physician thinks, oh no, it's something else […] then, no, I don't [report]. (O7)
Another participant also explained how they would notify the physician about the symptoms and let
the physician decide whether or not the TR should be reported (I14). As exemplified by these two
participants’ narratives, there is a group of participants who rely entirely on the physician’s
assessment and instructions to guide their reporting decisions.
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Compared to the few participants whose reporting decisions are solely based on physicians, most
participants lie on the middle of the spectrum, as they refer to the physician’s assessment only in
certain situations. Specifically, they would consult the physician about whether or not to report a
fever, which is a reaction often considered as not transfusion-related (as discussed in Section
4.3.2.1). Contrarily, they would use their own judgment to make reporting decisions when dealing
with TRs that are considered transfusion-related, such as MARs and more severe TRs. One
participant described how the physician has different levels of impact on their reporting decisions
for two types of TRs: “I guess we probably should put [fevers] on [reports], but for a low-grade
fever I don’t usually do anything other than speaking with the doctor […] unless [reporting] is what
he wants to do […] But if there is rash, rigours or anything, even minor, I would [report] it” (O2).
Another participant had a similar reporting behaviour as they let the physician decide whether to
report a fever, but they report a MAR “no matter what the doctor says” (I15).

4.3.1.3

Nurse’s Own Discretion

Several participants lie on the high end of the spectrum, as their reporting decisions are
independent of the physician’s assessment. This group of participants, like one participant said,
consider TR reporting as “an independent nursing thing” (O5). This participant further
commented: “I don't think the physicians can […] say, ‘Don't report, there's nothing’” (O5).
Another participant also gave an example of how they would use their own discretion to
determine whether to report a fever or not:
We don’t necessarily assume that [fever during a transfusion] is blood-related. It could just
be the fact that they’re septic […] and they continue to spike. There’s […] discretion based
on my assessment. If I feel that the patient is clinically […] septic, then I would always
assume that [fever] is nothing. But if the patient spikes a temperature [because] they’re
receiving blood products, then it is transfusion-related and I will fill out a [report] form.
(O1)

4.3.1.4

Institutional TR Diagnostic Guideline

At this institution, fever is defined as a febrile reaction in which 1) the patient’s body
temperature is greater than or equal to (≥) 38 C, and 2) the body temperature increases more
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than 1C from baseline temperature (LHSC & SJHCL, 2005). A minor allergic reaction (MAR)
is defined as a hive that covers less than two-thirds of the body surface (LHSC & SJHCL, 2005).
Some participants from the high end of the spectrum mentioned that they utilize the institutional
TR diagnostic guideline to assess TRs and determine which TRs need to be reported (LHSC &
SJHCL, 2005). All participants who mentioned the institutional criteria for fevers were able to
quote one of two criteria correctly, but not both. One participant said they would report a febrile
symptom “if the temperature increases a degree”, but they did not mention the criterion of “≥ 38
C” (I10). Another participant said that “[a fever] has to be over 38 or one degree greater than
what they started out as […] I would report if their temperature went up one degree over their
baseline or they went up to 38” (O4). This participant was aware of both criteria, but they
thought meeting either one of the criteria would constitute a fever. In addition, another
participant was aware of the criterion of “1 C increase”, but they missed the criterion of “≥ 38
C”:
Our definition of [fevers] is if they go above a whole degree. […] If they start off febrile
and they haven’t gone a full degree above, that’s not a true reaction so we wouldn’t
[report]. But if they weren’t febrile, and then they were [febrile during the transfusion], we
usually always do a [report] no matter what. (I12)
Nevertheless, unlike their confusion about the fever criteria, this participant described the
criterion for MARs correctly:
I’ve […] only ever seen one person with hives [covering] two-thirds of their body. So it
wasn’t that minor […] I’ve had another nurse’s patient had just one hive and even […] that
minor, we still report it. (I12)
Contrasting with the above participant who clearly identified the criterion of diagnosing and
reporting MARs, another participant was only able to describe the criterion of MARs vaguely
(O1). This participant said they would decide whether to report a MAR “according to the [report]
form, how [large] the body surface, perhaps” (O1).
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Barriers to TR Reporting
When participants were asked about their perspectives on the TR reporting process, four major
barriers to reporting TRs emerged from their responses: 1) the non-user-friendly reporting
system; 2) technical difficulties; 3) lack of understanding of the reporting process; and 4) busy
workload.

4.3.2.1

The Non-user-friendly Reporting System

The most predominantly reported barrier to TR reporting was the non-user-friendly reporting
system. Firstly, most participants considered the paper-based reporting process as redundant and
time-consuming. The information needed on the report form is the same as the information
nurses document on the patient’s EMR chart. Hence, having to enter the report order on EMR,
print the form, and manually fill in the information that is already documented online make
participants feel like they are doing the work twice. Except for one participant who was satisfied
with the current paper-based process (I3), many advocated for an online reporting system.
Participants mentioned three benefits of online reporting, which included avoiding the efforts of
printing and faxing paper forms, being consistent with other online documentation processes, and
allowing easier information sharing and access by all involved staff. Alternatively, one
participant suggested that the information from patients’ online charts should be auto-populated
onto printed report forms; in this way, nurses no longer need to manually fill in the duplicated
information such as patients’ vital signs (O4).
Secondly, one participant complained that putting in an online order for the report form is not a
straightforward process (I15). This participant explained that “when you go to [the EMR] to
order the report […] there are multiple options you can choose. So […] it can be a little bit
confusing to choose the right option” (I15). This participant suggested that “it’d be better if there
was just one option you could click [to order the report]” (I15).
Thirdly, one participant mentioned that the information about the patients’ TR history can not be
easily found on the patients’ EMR chart (I7). This participant said that “[the TR history] should
be made obvious on [the chart] if they’ve had a previous reaction. I don’t think that’s very
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clearly identified” (I7). Accordingly, this participant recommended that the information about
TR history should be visually flagged on the patient’s EMR chart (I7).

4.3.2.2

Technical Difficulties

Technical difficulties in the paper-based reporting process were identified as the second-largest
barrier to reporting TRs. Both units experienced printing issues with paper report forms. For instance,
one participant from the inpatient unit described the difficulties and inefficiency they experienced
when the forms did not print:
In previous times that I’ve had to [report] a reaction […] it’s always so hard to print it and
I’ve had to call downstairs at the [TML] a couple of times so that they could send me the
report sheet for me to fill in […] once we order [the report] it’s supposed to print […] But
most often that doesn’t work […] so we always have to run around […] waste time finding
another sheet. (I13)
The issues with printing forms were also mentioned by several participants from the outpatient
unit. For example, one participant said that due to printing issues, “our clinical educator has
basically provided an attachment [of the report form] on an e-mail since it’s not printing” (O1).
When TR reports need to be done, this participant “automatically defaults to the e-mail” because
they anticipate the printing issues (O1).
In addition to the printing issues, a couple of participants from the outpatient unit also complained
about the hassle of faxing report forms. One participant thought that “faxing is annoying because
we only have one fax machine and it’s all the way over on the other side of the unit” (O3). Another
participant also mentioned the issue of having only one fax machine in their unit, and further
explained that nurses have to leave the bedside to complete faxing tasks, which they consider not
user-friendly (O7).

4.3.2.3

Lack of Understanding of the Reporting Process

A few participants shared that they lack understanding of the TR reporting system and its
process, as they had little to no experience reporting TRs. For example, one participant who has
never handled or reported a TR, stated that they would “feel a little bit nervous and lost […] as
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far as the paperwork […] I don’t know if I would know all the details […] I don’t feel a hundred
percent confident” (I11).
Some other participants who have reported TRs before also expressed different frustrations about
the reporting process. One participants did not know how to order the report form online (I6). As
they said, “I think it’s on [the EMR] but it just isn’t clear to me […] I’m not sure what to select
on [the EMR]” (I6). Another participant was unsure whether the paper report form needs to be
filled out (I8). They were told that “even if the [report form] prints off, [they] only have to chart
it online” (I8). However, they were also told differently that “the [TML] […] still want the paper
[report form]” (I8). This participant suggested that “there might be a little bit of clarification
needed […] whether or not we actually have to do both [the online charting and the paper report
form]” (I8).

4.3.2.4

Busy Workload

A couple of participants identified busy workload as a barrier to reporting TRs. One participant
described the dilemma of not being able to complete TR reports in a timely manner when busy:
“Sometimes it gets busy and maybe our reaction time may not be as quickly as we want […]
that’s probably more of a staffing issue rather than the actual process of filling out a report” (I6).
Another participant shared a similar concern: “It’s just a matter of finding time to fill out [the
report] if we’re busy. That’s more the issue than anything else” (O2).

Facilitators to TR Reporting
When being interviewed about their opinions on the TR reporting process, participants described
two major facilitators to TR reporting: 1) collaboration between staff; and 2) resources about TR
reporting.

4.3.3.1

Collaboration between Staff

The most identified facilitator to TR reporting is the collaboration between staff, especially
between nurses. One participant described that when TRs happen, “[nurses] all work together
and it’s teamwork” (O8). Another participant who lacked experience of TR reporting was
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confident in the support their fellow nurses could provide: “If I had to do [a TR report], I would
ask my coworkers because I’ve obviously never done it” (I11).
In addition to the collaborations between nurses, physicians also facilitate the TR reporting
process by providing nurses with assessments of suspected TRs (Section 4.3.1.2) and sometimes
ordering TR reports for nurses (Section 4.3).
Moreover, the TML provides support to nurses during their TR reporting process. The TML not
only provides report forms to nurses when they encounter technical difficulties (Section 4.3.3.2),
but also provides guidance and instructions when nurses need clarification about the reporting
process. For instance, one participant shared experience of having the TML help them manage
and report a TR:
I just talked to the [TML] lady because [the patient] had a reaction. [The TML lady] said
they normally have to send the blood back [to the TML], stop the transfusion and all this
stuff. I haven’t seen [a report form]. I know it’s an order on [the EMR], but I haven’t had
to do it before […] I think the [TML] is pretty good about telling us what we need to do.
(I14)

4.3.3.2

Resources about TR Reporting

Resources that provide guidance on TR reporting were also considered as a facilitator to TR
reporting. Specifically, an institutional online transfusion practice manual was mentioned by a
few participants. For example, one participant introduced that “we have a whole transfusion
[manual], like if minor reactions what to do [versus] if it’s fever […] it’s all online for us and
that’s what I always look at” (I12).
Other than the online transfusion manual that is already in place, the participants also suggested
other resources that would be desirable. A couple of participants recommended posters that show
TR managing and reporting guideline to be posted on the unit walls as a quicker reference.
Similarly, one participant suggested pocket cards with printed guideline that can be carried
around by nurses (O4). Furthermore, educational tools that educate nurses about TR managing
and reporting practices were considered helpful. Most participants prefer having an in-service
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educator over an online education module. As one participant explained, nurses would “be able
to ask questions or have somebody [during the education session] to show [the process on]
computers” if educators hold educational sessions in their units (O4).

Summary
Section 4.3 presents the results of the nursing practices of TR reporting at the studied institution.
Three major themes that emerged from the data—1) factors that impact nurses’ TR reporting
practices; 2) barriers to TR reporting; and 3) facilitators to TR reporting—were divided into subthemes and described in details.
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Chapter 5

5

Discussion and Conclusion

In this chapter, the study findings are discussed in relation to the literature. Aligned with the
qualitative description approach, the researchers’ interpretation was maintained at a level that KT
stakeholders can easily understand and relate to. The study’s contributions, strengths and
limitations are also discussed. This chapter ends with the significance of the study and how it
informs the overall KT project, followed by a conclusion of the study.

5.1 Study Findings in Relation to Literature
Current Practices of Premedication
This study explored the current practices of premedication by interviewing nurses in the adult
oncology inpatient unit and the adult oncology outpatient unit at the studied institution. Some
previous studies have evaluated the use of premedication (Ezidiegwu et al., 2004; Fry et al.,
2010; Kennedy et al., 2008; Sanders et al., 2005; Wang et al., 2002). These studies focused on
the efficacy and cost-effectiveness of premedication using randomized controlled trial or
retrospective chart review designs. By utilizing a unique interviewing approach, this study
generated new knowledge about the practices and nursing perspectives of premedication.
The study results revealed the different roles of health care professionals in premedication
practices, which have not been discussed in previous literature. Three groups of health care
professionals are involved in the process of premedicating patients before transfusions. Firstly,
the prescribers, including physicians, residents and nurse practitioners, has the privilege to
prescribe premedication. This finding informs the KT project that interventions to reduce
premedication should be designed to target prescribers, who are the ultimate decision-makers of
premedication. Secondly, an interesting finding about nurses’ roles was that they not only follow
premedication orders from prescribers, but advocate for premedication when they think
premedication is necessary. As the current study focused only on nurses’ narratives, prescribers
should be involved in future research to understand the extent to which nurses’ advocacy impact
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their premedication decision-making. Assuming a certain level of impact, the KT team should
consider nurses as another important stakeholders when they design interventions to reduce
premedication. Moreover, one participant would not necessarily notify prescribers if they learn
about the TR history from patients and judge that the past TRs were minor enough not to require
premedication. Therefore, in addition to advocating for premedication, nurses may also intervene
with prescribers’ premedication decision-making by not reporting minor TR history to
prescribers. This behaviour is undesirable because all TRs meeting criteria should be
documented and reported to both prescribers and the TML. This behaviour may not represent the
practices of the whole nursing population because only one of 25 participants reported it.
However, it revealed a lack of understanding of the importance of TR reporting and pointed to an
area where education is needed. Furthermore, nurses considered the TML’s recommendations of
premedication helpful for guiding their advocacy decisions. This finding revealed that the TML
is considered by nurses as an authority of transfusion-related information. Thus, the KT team
should utilize the TML’s authority and influence in their interventions to implement evidencebased premedication practices. For example, in the future when nurses and prescribers contact
the TML for support, the TML can actively take on an educator’s role and educate them about
the current best evidence on premedication and provide alternative treatment options.
Other than the three groups of health care professionals—prescribers, nurses, and the TML
staff—who impact the decision to premedicate, the most predominantly reported factor that
impacts the premedication decision-making was the patient’s transfusion history. A national
survey with Canadian paediatric physicians found that no respondent would premedicate for all
red blood cell or all platelet transfusions (Solh et al., 2016). The current study expanded on Solh
et al.’s (2016) findings and showed that that premedication is not a universal treatment for all
transfused patients, but a treatment that is believed to be suitable only for patients with a TR
history. The influencing factor of “the existence of TR history” echoes the inclusion criteria of
Wang et al.’s (2002) randomized controlled trial, where they included patients with a history of
TRs to examine the efficacy of acetaminophen and diphenhydramine as premedication. Their
study found that acetaminophen and diphenhydramine given prior to platelet transfusions did not
significantly lower the incidence of TRs compared to placebo. A few participants believed that
patients’ not only need to have a TR history, but need to experience repeated TRs in the past
before being prescribed premedication. Their narratives are consistent with the Ontario Regional
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Blood Coordinating Network’s statement that: “Premedication [is] generally only recommended
for patients who have previously experienced repeated transfusion reactions” (Lima, 2015).
In summary, this study explored the current premedication practices at the studied institution and
identified prescribers, nurses, and the TML staff as three main groups of health care
professionals that engage in and impact the premedication decision-making process. According
to participants, premedication is a common treatment for patients with a history of TRs.
Considering evidence showing the lack of efficacy and cost-effectiveness of premedication, we
identified a need for change in the premedication practices at this institution.

Barriers and Facilitators to Reducing Premedication
A major barrier to reducing the use of premedication was nurses’ beliefs in the efficacy of
premedication despite the lack of evidence supporting their beliefs. When being asked about their
opinions on premedication, all participants believed in the efficacy of premedication in preventing
TRs. None of them were aware of the evidence showing the lack of efficacy of premedication
(Marti-Carvajal et al., 2010; Sanders et al., 2005; Tobian et al., 2007). Besides a couple of
participants who shared anecdotes of observing the efficacy of premedication, most participants
held subjective beliefs in premedication and did not provide any observations or evidence to support
their beliefs. Their wordings such as “less risk of complications” (I15), “peace of mind” (I8) and
“more comfortable and […] less scary [for patients]” (O4) suggested that nurses’ beliefs in
premedication are likely linked to the risk-averse nature of health care. With the anticipation that
TRs may happen, the use of premedication may provide emotional support to both health care
professionals and patients that some aspects of the risks “[have] been looked after” (I8). Altogether,
the perspectives of premedication held by nurses at this institution are not evidence-based but
emotion-based. In order to implement evidence-based premedication practices at this institution,
education is needed to raise nurses’ awareness of the current best evidence against premedication.
The second barrier to reducing premedication was the lack of a standardized premedication practice
at this institution. One participant shared their observation that premedication practices vary
between different prescribers (A17). This participant further interpreted that the decision of whether,
what and whom to premedicate may differ based on different prescribers’ preferences and
experiences (A17). Furthermore, many participants reported a variety of premedication approaches
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to prevent fevers during transfusions. Some participants observed that patients with past febrile
reactions are not consistently premedicated because fevers are often considered as not transfusionrelated, while others stated that patients with a history of fevers are commonly premedicated. The
differences in participants’ narratives and observations show the lack of a standardized
premedication practice at this institution. Different premedication practices also imply that
prescribers may face a diagnostic dilemma when they need to decide whether to premedicate a
previously febrile patient. Similar to the findings of this study, Solh et al.’s (2016) national survey
revealed the lack of standardized premedication practices across Canadian hospitals. None of the 16
hospitals participating in the survey have a premedication clinical practice guideline (Solh et al.,
2016). Solh et al.’s (2016) study further showed that a majority of survey respondents desired a
premedication practice guideline at their hospitals. Therefore, implementing a clinical practice
guideline that reflects current evidence against routine premedication may be an effective
intervention to help standardize the premedication practices and reduce the use of premedication at
this institution.
The third identified barrier to reducing premedication was the lack of awareness of TR prevention
methods alternative to premedication. Only one participant showed awareness of alternative
methods that the TML provides to prevent TRs (I14). This participant gave an example of
transfusing irradiated blood products, which is a proven effective method to prevent a fetal TR called
graft-versus-host disease (Waller et al., 1999). Similarly, a previous study also revealed that
physicians in Canadian hospitals lack knowledge about blood product manipulation methods such
as leukoreduction, an effective blood processing technique that is proven to reduce the incidence of
febrile reactions and is universally applied to Canada’s blood supply (Solh et al., 2016). To address
this barrier, further education is necessary to educate health care professional about available
evidence-based TR prevention methods. In addition, Solh et al. (2006) suggested that a
premedication standard order set can be implemented to shift prescribers’ focus from prescribing
premedication to manipulating blood components as TR prevention methods.
A facilitator to reducing premedication was that most participants were aware of the side effects of
premedication, specifically the drowsiness associated with the use of diphenhydramine. Participants
were concerned about the transportation difficulties and extended discharge time caused by the use
of diphenhydramine as premedication. Thus, we speculate that some underlying mental calculations
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on the cost-effectiveness of premedication are involved in health care professionals’ minds during
the premedication decision-making process. Ezidiegwu et al. (2004) conducted a cost-effectiveness
analysis of premedication and found that the use of premedication does not yield significant cost
effectiveness for health care professionals and their institutions. Christensen et al. (2019) also
suggest that using premedication is a source of financial burden and medical waste without known
efficacy to decrease TRs. Therefore, if the mental cost-effectiveness analysis of health care
professionals can be leveraged by some interventions, the practices of administering premedication
should reduce.

Current Practices of TR Reporting
This study found that nurses take a major responsibility in the TR reporting process. TR reports
are often initiated and ordered by nurses and are always completed by nurses at this institution.
This finding resonates with Hussain et al.’s (2015) clinical audit study where they assessed the
frequency of receiving completely filled TR forms at their institution. At their institution, nurses
are also credentialed for transfusions, and their tasks include monitoring the patient’s vital signs,
managing the TR, and completing the TR form (Hussain et al., 2015). As the current study
confirmed that nurses are the major stakeholders of TR reporting at this institution, we
recommend selecting them as the targeted population for interventions to improve TR reporting.
The practices of reporting fevers and reporting MARs were found to be distinctly different.
Fevers are inconsistently reported to the TML, while MARs are often reported. These
inconsistent reporting practices resonate with Narvios et al. ’s (2004) study, in which they
monitored and collected information about unreported TRs using a questionnaire in an oncology
inpatient unit at their hospital. Narvios et al. (2004) found that under-reporting of minor TRs
such as fevers and MARs exists, compared to our institution where only fevers are inconsistently
reported. After analyzing participants’ rationales for not reporting fevers and for reporting
MARs, we speculate that whether or not a symptom is considered transfusion-related decides
whether or not it gets reported. With the presence of confounding pre-existing fevers, fevers are
often considered not transfusion-related and therefore, not reported to the TML. Contrarily,
MARs are usually not associated with any pre-transfusion allergic symptoms. Thus, when MARs
happen during transfusions, they are often considered transfusion-related and are properly
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reported. However, as a sentinel site of the TTISS-ON, this institution is expected to report all
minor TRs meeting the diagnostic criteria, no matter considered transfusion-related or not by the
health care professionals (LHSC & SJHCL, 2005).
The nursing practices of TR reporting also vary across a spectrum (Figure 2), on which nurses
with low independence in TR reporting decide whether to report based on physicians’
assessments, and nurses with high independence decide whether to report a TR using their own
discretion. For nurses with high independence in TR reporting, some reported using the
institutional diagnostic guideline to assess TRs and determine which ones need to be reported.
Although these participants were aware of the importance of using guideline and criteria, none of
them quoted the criteria for diagnosing fevers correctly, which showed their unfamiliarity with
the TR diagnostic criteria.
Therefore, we concluded that the nursing practices of TR reporting are inconsistent and not
standardized to meet the institutional reporting guideline and expectation. Furthermore, we found
that nurses have poor awareness of the importance of reporting all TRs that meet the criteria. As
good TR reporting practices are an important foundation for implementing evidence-based
transfusion practices by providing the most accurate data about TRs, we identified a need for
improving the TR reporting practices at this institution (Solh et al., 2016). To do so, we will need
to raise nurses’ awareness of the importance of reporting all TRs meeting the criteria. We also
need to educate nurses to follow the institutional reporting guideline instead of physicians’ and
their own judgments when deciding whether to report TRs. Nurses need to be trained to become
more familiar with the institutional TR diagnostic criteria used at this institution.

Barriers and Facilitators to Improving TR Reporting
Four barriers to TR reporting, perceived by the participants, were: 1) the non-user-friendly
reporting system; 2) technical difficulties; 3) the lack of understanding of the reporting process;
and 4) busy workload.
Most participants considered the paper-based reporting system redundant and time-consuming.
Paper report forms require nurses to manually fill the information that has already been
documented online on the EMR. In addition, many participants experienced printing issues
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during the paper-based reporting process, in which TR report forms would not print properly
following online orders. Due to the limited number of fax machines, the faxing process was also
inconvenient in one of the interviewed units. Considering these barriers, most participants
suggested moving towards an online reporting system. Participants identified three benefits of
online reporting, which included avoiding the effort of printing and faxing paper forms, being
consistent with other online documentation processes, and allowing easier information sharing
and access by all involved staff. The benefits of an online reporting system were also discussed
in Yeh et al. ’s (2011) study, where they evaluated the convenience and clinical impact of a
newly designed online reporting system to replace the paper-based reporting system at their
hospital. The new online reporting system increased the documented incidence of TRs from
0.21% to 0.61% per unit of blood products within a year (Yeh et al., 2011). About 80% of nurses
considered the workload of reporting to be decreased or the same (Yeh et al., 2011). Therefore,
an online TR reporting system will be a desirable intervention that may target three of the four
identified barriers by replacing the paper-based system, avoiding technical difficulties
encountered during the printing and faxing processes, and reducing the busy workload of nurses.
Of course, as one participant pointed out, the busy workload is ultimately an institutional
“staffing issue” (I6), which is out of the scope of this study.
A few participants with little experience of TR reporting shared their lack of understanding about
the reporting process. Even some participants who have experience reporting TRs expressed
frustration about the reporting process. For example, although the correct reporting process
involves faxing a report form with all required information filled in, one participant presumed
that they only need to fax an incomplete form as a way to notify the TML to look for more TR
information on the EMR. Undesirable reporting practices like the previous example should be
addressed and changed through education on the proper way of TR reporting.

5.2 Study Contributions and Strengths
Firstly, as a needs assessment and a barriers assessment of the overall KT project, the findings of
this study assist in the development and delivery of interventions for evidence-based transfusion
practices, including reducing premedication and improving TR reporting, at the studied
institution.
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Secondly, this study contributes to the literature by exploring the nursing practices and
perspectives of premedication and TR reporting. To the best of our knowledge, there are no other
studies that have examined these topics previously. The practices, barriers and facilitators
discussed here may resonate with other health care organizations that aim to conduct KT or
quality improvement projects in clinical transfusion medicine.
Lastly, this study utilizes the approach of a qualitative description study, a type of study that is
practical and suitable for healthcare-related KT projects to fill the knowledge-practice gap and to
bring about practice change. Therefore, this study serves as an example for other researchers
aiming to conduct needs and barriers assessments for their KT projects, especially using a
constructivist paradigm and qualitative description approach.

5.3 Study Limitations
Firstly, this study did not explore prescribers’ practices and perspectives of premedication. As
prescribers were identified as the ultimate decision-makers regarding the use of premedication,
we could have interviewed them to further understand the need for and the barriers and
facilitators to reducing premedication at this institution.
Secondly, demographic data on participants’ level of experience in transfusion were not
collected. As we found that nurses’ independence in TR reporting varies across a spectrum,
information about nurses’ experience could have been helpful to examine the correlation
between the level of nurse’s experience in transfusion and their independence in TR reporting.
Lastly, future research for the KT project may use a mixed-methods design with quantitative
data. Given that this study is within the constructivist paradigm, the differences in paradigms and
philosophical assumptions between studies may affect meaningful coherence and resonance
(Tracy, 2010).

5.4 Implications for the KT Project
The findings of this study showed that there is a need for change in the premedication and TR
reporting practices at the studied institution. Additional research is needed to further examine
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prescribers’ practices and perspectives of premedication. Future research should also investigate
the correlation between the nurse’s experience in transfusion and their independence in reporting
TRs.
A premedication practice guideline was identified as a beneficial tool to reduce the use of
premedication at this institution. If the institution implements a guideline supporting a reduced
use of premedication, TRs should not be expected to increase in frequency, and the main benefits
would be an alignment with the current best evidence and a potential reduction in financial costs
for patients and the institution (Solh et al., 2016).
An online TR reporting system is also a desirable intervention to eliminate the barriers
encountered during the current paper-based reporting process. With the implementation of an
online reporting system, one can expect an increased TR reporting rate and reporting efficiency
and decreased technical difficulties in the reporting process.
Furthermore, educational tools are also necessary to increase health care professionals’
understanding of the following topics: 1) evidence showing the lack of efficacy and costeffectiveness of premedication; 2) evidence-based TR prevention methods as alternatives to
premedication; 3) the importance of using institutional diagnostic criteria to make TR reporting
decisions; and 4) the correct and expected way to complete TR reporting.

5.5 Conclusion
As part of a KT project to implement evidence-based premedication and TR reporting practices,
this study performed a needs assessment and a barriers assessment at the studied institution. The
study lay in the constructivist paradigm and used a qualitative description study design. The
researchers aimed to understand the nursing practices and perspectives of premedication and TR
reporting by interviewing 25 nurses from the adult oncology inpatient unit and adult oncology
outpatient unit at this institution. The study showed the lack of a standardized premedication
practice and the need for change in premedication practices at this institution. Nurses have poor
awareness of evidence against the use of premedication. Barriers and facilitators to reducing
premedication were identified. The study also revealed that the nursing practices of TR reporting
are not standardized to meet the institutional reporting guideline. Under-reporting of fevers exists
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at this institution. There is a need for change in TR reporting practices to achieve best practice.
Barriers and facilitators to improving TR reporting practices were identified.
The findings of this study contribute to the literature by exploring the nursing practices and
perspectives of premedication and TR reporting, which are novel topics that have not been
studied before. Barriers and facilitators identified in this study inform the overall KT project and
help tailor appropriate interventions to reduce the use of premedication, improve TR reporting,
and ultimately implement evidence-based transfusion practices at the studied institution.

56

References
Agency for Healthcare Research and Quality [AHRQ]. (2017). Ways to Approach the Quality
Improvement Process. Retrieved from
https://www.ahrq.gov/sites/default/files/wysiwyg/cahps/quality-improvement/improvementguide/4-approach-qi-process/cahps-section-4-ways-to-approach-qi-process.pdf
Banerji, A., Long, A. A., & Camargo, C. A. (2007). Diphenhydramine versus nonsedating
antihistamines for acute allergic reactions: A literature review. Allergy and Asthma
Proceedings, 28(4), 418–426. https://doi.org/10.2500/aap.2007.28.3015
Beauchamp, T. L., & Childress, J. F. (2009). Principles of Biomedical Ethics (6th ed.). New
York: Oxford University Press.
Bolton-Maggs, P. H. B., & Cohen, H. (2013). Serious Hazards of Transfusion (SHOT)
haemovigilance and progress is improving transfusion safety. British Journal of
Haematology, 163(3), 303–314. https://doi.org/10.1111/bjh.12547
Botting, R. (2000). Mechanism of action of acetaminophen: Is there a cyclooxygenase 3?
Clinical Infectious Diseases, 31, 202-210. https://doi.org/10.1086/317520
Bradshaw, C., Atkinson, S., & Doody, O. (2017). Employing a qualitative description approach
in health care research. Global Qualitative Nursing Research, 4, 1–8.
https://doi.org/10.1177/2333393617742282
Callum, J., Pinkerton, P., Lima, A., Lin, Y., Karkouti, K., Lieberman, L., … Webert, K. (2017).
Adverse reactions. In Clinical Guide to Transfusion. Canadian Blood Services. Retrieved
from https://professionaleducation.blood.ca/en/transfusion/guide-clinique/adverse-reactions
Canadian Institute for Health Research [CIHR]. (2007). About knowledge translation. (2007).
Retrieved from http://www.cihr-irsc.gc.ca/e/29418.html
Carpenter, C., & Suto, M. (2008). Why choose qualitative research in rehabilitation? In
Qualitative Research for Occupational and Physical Therapists: A Practical Guide (pp. 21–
39). Oxford: Blackwell Pub. Retrieved from https://www.wiley.com/en-

57

ca/Qualitative+Research+for+Occupational+and+Physical+Therapists:+A+Practical+Guide
-p-9781405144353
Chafe, R. (2017). The value of qualitative description in health services and policy research.
Healthcare Policy, 12(3), 12–18. https://doi.org/10.1177/2333393617742282
Christensen, B. W., Rubinstein, S. M., Bastakoty, D., Savani, B. N., & Booth, G. S. (2019). A
retrospective cost analysis of the frequency and cost of transfusion premedications.
Transfusion, 9999, 1–5. https://doi.org/10.1111/trf.15301
Clarke, G. (2017). Blood components. Clinical Guide to Transfusion. Retrieved from
https://professionaleducation.blood.ca/en/transfusion/guide-clinique/blood-components
Clarke, V., & Braun, V. (2012). Thematic analysis. In H. Cooper (Ed.), APA Handbook of
Research Methods in Psychology (Vol. 2, pp. 57–71). American Psychological Association.
https://doi.org/10.1080/17439760.2016.1262613
Creswell, J. W. (2013). Qualitative Inquiry and Research Design: Choosing Among Five
Approaches (3rd ed.). Los Angeles: SAGE Publications.
De Vries, R. R. P., Faber, J. C., & Strengers, P. F. W. (2011). Haemovigilance: An effective tool
for improving transfusion practice. Vox Sanguinis, 100, 60–67.
https://doi.org/10.1111/j.1423-0410.2010.01442.x
Debeir, J., Noel, L., Aullen, J.-P., Frette, C., Sari, F., Vo Mai, M. P., & Cosson, A. (1999). The
French haemovigilance system. Vox Sanguinis, 77(2), 77–81.
https://doi.org/10.1159/000031080
Dicicco-Bloom, B., & Crabtree, B. F. (2006). The qualitative research interview. Medical
Education, 40, 314–321. https://doi.org/10.1111/j.1365-2929.2006.02418.x
Duncan, J. (2018). Ontario Transfusion Transmitted Injuries Surveillance System (TTISS-ON).
Ontario Regional Blood Coordinating Network. Retrieved from
http://transfusionontario.org/en/december-2018/

58

Duran, J., Siddique, S., & Cleary, M. (2014). Effects of leukoreduction and premedication with
acetaminophen and diphenhydramine in minimizing febrile nonhemolytic transfusion
reactions and allergic transfusion reactions during and after blood product administration: A
literature review with recommendations for practice. Journal of Pediatric Oncology
Nursing, 31(4), 223–229. http://doi.org/10.1177/1043454214532029
Ezidiegwu, C. N., Lauenstein, K. J., Rosales, L. G., Kelly, K. C., & Henry, J. B. (2004). Febrile
nonhemolytic transfusion reactions: Management by premedication and cost implications in
adult patients. Archives of Pathology & Laboratory Medicine, 128(9), 991–995.
https://doi.org/10.1016/b978-012348775-9/50080-6
Faber, J.-C. (2004). Worldwide overview of existing haemovigilance systems. Transfusion and
Apheresis Science, 31(2), 99–110. https://doi.org/10.1016/J.TRANSCI.2004.07.004
Finlay, L. (2002). “Outing” the researcher: The provenance, process, and practice of reflexivity.
Qualitative Health Research, 12(4), 531–545. Retrieved from https://journalsscholarsportal-info.proxy1.lib.uwo.ca/pdf/10497323/v12i0004/531_trtppapor.xml
Fox, R. C. (2004). Observations and reflections of a perpetual fieldworker. The Annals of the
American Academy of Political and Social Science, 595(1), 309–326.
https://doi.org/10.1177/0002716204266635
Fry, J. L., Arnold, D. M., Clase, C. M., Crowther, M. A., Holbrook, A. M., Traore, A. N., …
Heddle, N. M. (2010). Transfusion premedication to prevent acute transfusion reactions: A
retrospective observational study to assess current practices. Transfusion, 50(8), 1722–
1730. https://doi.org/10.1111/j.1537-2995.2010.02636.x
Geiger, T. L., & Howard, S. C. (2007). Acetaminophen and diphenhydramine premedication for
allergic and febrile non-hemolytic transfusion reactions : Good prophylaxis or bad practice?
Transfusion Medicine Reviews, 21(1), 1–12. https://doi.org/10.1016/j.tmrv.2006.09.001
Given, Lisa M. (2016). 100 Questions (and Answers) about Qualitative Research. Thousand
Oaks, CA: SAGE Publications.

59

Glaser, B. G., Strauss, A. L., & Strutzel, E. (1967). The Discovery of Grounded Theory:
Strategies for Qualitative Research. Chicago: Aldine Publishing Co.
https://doi.org/10.1097/00006199-196807000-00014
Government of Canada [GOC]. (2014). Transfusion Transmitted Injuries Surveillance System.
Retrieved from https://www.canada.ca/en/public-health/services/surveillance/blood-safetycontribution-program/transfusion-transmitted-injuries-surveillance-system.html
Grady, M. P. (1998). Qualitative and Action Research: A Practitioner Handbook. Bloomington:
Phi Delta Kappa Educational Foundation.
Graham, I. D., Logan, J., Harrison, M. B., Straus, S. E., Tetroe, J., Caswell, W., & Robinson, N.
(2006). Lost in knowledge translation: Time for a map? The Journal of Continuing
Education in the Health Professions, 26(1), 13–24. https://doi.org/10.1002/chp.47
Grol, R., & Grimshaw, J. (2003). From best evidence to best practice: Effective implementation
of change in patients’ care. The Lancet, 362, 1225–1230. https://doi.org/10.1016/S01406736(03)14546-1
Guba, E. G. (1990). The alternative paradigm dialog. In The Paradigm Dialog (pp. 17–27).
Thousand Oaks, CA: SAGE Publications. Retrieved from
https://psycnet.apa.org/record/1990-98838-001
Guba, E. G., & Lincoln, Y. S. (1994). Competing paradigms in qualitative research. In
Handbook of Qualitative Research. Thousand Oaks, CA: SAGE Publications. Retrieved
from https://psycnet.apa.org/record/1994-98625-005
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment
with data saturation and variability. Field Methods, 18(1), 59–82.
https://doi.org/10.1177/1525822X05279903
Hawkins, B. T., & Egleton, R. D. (2008). Pathophysiology of the bloodbrain barrier: Animal
models and methods. Current Topics in Developmental Biology, 80, 277–309. http://doi.org
10.1016/S0070-2153(07)80007-X

60

Heddle, N. M., Klama, L. N., Griffith, L., Roberts, R., Shukla, G., & Kelton, J. G. (1993). A
prospective study to identify the risk factors associated with acute reactions to platelet and
red cell transfusions. Transfusion, 33, 794–797. http://doi.org/10.1046/j.15372995.1993.331094054613.x
Hinson, J. A., Reid, A. B., McCullough, S. S., & James, L. P. (2004). Acetaminophen‐induced
hepatotoxicity: Role of metabolic activation, reactive oxygen/nitrogen species, and
mitochondrial permeability transition. Drug Metabolism Reviews, 36(3–4), 805–822.
https://doi.org/10.1081/DMR-200033494
Huff, A. S. (2008). Designing Research for Publication (1st ed.). Thousand Oaks, CA: SAGE
Publications.
Hussain, S., Moiz, B., Ausat, F. A., & Khurshid, M. (2015). Monitoring and reporting
transfusion reactions as a quality indicator – a clinical audit. Transfusion and Apheresis
Science, 52(1), 122–127. https://doi.org/10.1016/j.transci.2014.03.012
Juji, T., Nishimura, M., Watanabe, Y., Uchida, S., Okazaki, H., & Tadokoro, K. (2009).
Transfusion-associated graft-versus-host disease. ISBT Science Series, 4(2), 236–240.
https://doi.org/10.1111/j.1751-2824.2009.01242.x
Kennedy, L. D., Case, L. D., Hurd, D. D., Cruz, J. M., & Pomper, G. J. (2008). A prospective,
randomized, double-blind controlled trial of acetaminophen and diphenhydramine
pretransfusion medication versus placebo for the prevention of transfusion reactions.
Transfusion, 48(11), 2285–2291. https://doi.org/10.1111/j.1537-2995.2008.01858.x
Kim, H., Sefcik, J. S., & Bradway, C. (2017). Characteristics of qualitative descriptive studies: A
systematic review. Research in Nursing & Health, 40(1), 23–42.
https://doi.org/10.1002/nur.21768
King, K. E., Shirey, R. S., Thoman, S. K., Bensen-Kennedy, D., Tanz, W. S., & Ness, P. M.
(2004). Universal leukoreduction decreases the incidence of febrile nonhemolytic
transfusion reactions to RBCs. Transfusion, 44(1), 25–29. https://doi.org/10.1046/j.00411132.2004.00609.x

61

Kothari, A., & Wathen, C. N. (2013). A critical second look at integrated knowledge translation.
Health Policy, 109, 187–191. https://doi.org/10.1016/j.healthpol.2012.11.004
Lima, A. (2015). Bloody Easy Blood Administration Handbook (2nd ed.). Toronto: Ontario
Regional Blood Coordinating Network.
London Health Sciences Centre & St Joseph's Health Care London [LHSC & SJHCL]. (2005).
Acute reaction management - TRAC: Reporting adverse effects of transfusion. Blood
Transfusion Clinical Practice Manual. Retrieved from
http://www.lhsc.on.ca/palm/labs/transfusion.html#main-content
Marti-Carvajal, A. J., Sola, I., Gonzalez, L. E., Leon de Gonzalez, G., & Rodriguez-Malagon, N.
(2010). Pharmacological interventions for the prevention of allergic and febrile nonhaemolytic transfusion reactions. Cochrane Database of Systematic Reviews, (6), 1–34.
https://doi.org/10.1002/14651858.CD007539.pub2.
McClelland, B., Love, E., Scott, S., & Williamson, L. M. (1998). Haemovigilance: Concept,
Europe and UK initiatives. Vox Sanguinis, 74(S2), 431–439. https://doi.org/10.1111/j.14230410.1998.tb05453.x
Menitove, J. E. (1998). Hemovigilance in the United States of America. Vox Sanguinis, 74(S2),
447–455. https://doi.org/10.1111/j.1423-0410.1998.tb05455.x
Miles, M. B., Huberman, A. M., & Saldana, J. (2014). Qualitative Data Analysis: A Method
Sourcebook (3rd ed.). Thousand Oaks, CA: SAGE Publications.
https://doi.org/10.2307/1163741
Minkler, M. (2004). Ethical challenges for the “outside” researcher in community-based
participatory research. Health Education & Behavior, 31(6), 684–697.
https://doi.org/10.1177/1090198104269566
Narvios, A. B., Lichtiger, B., & Newman, J. L. (2004). Underreporting of minor transfusion
reactions in cancer patients. Medscape General Medicine, 6(2), 17. Retrieved from
http://vr2pk9sx9w.search.serialssolutions.com/?ctx_ver=Z39.882004&ctx_enc=info%3Aofi%2Fenc%3AUTF-

62

8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt
%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Underreporting+of+minor+tra
National Heart, Lung, and Blood Institute [NHLBI]. (n.d.). Blood Transfusion. Retrieved from
https://www.nhlbi.nih.gov/health-topics/blood-transfusion
Neergaard, M. A., Olesen, F., Andersen, R. S., & Sondergaard, J. (2009). Qualitative description
- the poor cousin of health research? BMC Medical Research Methodology, 9(52), 1–5.
https://doi.org/10.1186/1471-2288-9-52
Paglino, J. C., Pomper, G. J., Fisch, G. S., Champion, M. H., & Snyder, E. L. (2004). Reduction
of febrile but not allergic reactions to RBCs and platelets after conversion to universal
prestorage leukoreduction. Transfusion, 44(1), 16–24. https://doi.org/10.1046/j.00411132.2004.00608.x
Palinkas, L. A., Horwitz, S. M., Green, C. A., Wisdom, J. P., Duan, N., & Hoagwood, K. (2015).
Purposeful sampling for qualitative data collection and analysis in mixed method
implementation research. Administration and Policy in Mental Health and Mental Health
Services Research, 42, 533–544. https://doi.org/10.1007/s10488-013-0528-y
Patterson, B. J., Freedman, J., Blanchette, V., Sher, G., Pinkerton, P., Hannach, B., … Patterson,
B. J. (2000). Effect of premedication guidelines and leukoreduction on the rate of febrile
nonhaemolytic platelet transfusion reactions. Transfusion Medicine, 10, 199-206. Retrieved
from https://journals-scholarsportalinfo.proxy1.lib.uwo.ca/pdf/09587578/v10i0003/199_eopgalofnptr.xml
Patton, M. Q. (1999). Enhancing the quality and credibility of qualitative analysis. Health
Services Research, 34, 1189–1208. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/10591279
Patton, M. Q. (2002). Qualitative Research and Evaluation Methods (3rd. ed.). Thousand Oaks,
CA: SAGE Publications.
Perrotta, P. L., & Snyder, E. L. (2001). Non-infectious complications of transfusion therapy.
Blood Reviews, 15, 69–83. https://doi.org/10.1054/blre.2001.0151

63

Ponterotto, J. G. (2005). Qualitative research in counseling psychology: A primer on research
paradigms and philosophy of science. Journal of Counseling Psychology, 52(2), 126–136.
https://doi.org/10.1037/0022-0167.52.2.126
Pruss, A., Kalus, U., Radtke, H., Koscielny, U., Baumann-Baretti, A., Balzer, D., … Kiesewetter,
H. (2004). Universal leukodepletion of blood components results in a significant reduction
of febrile non-hemolytic but not allergic transfusion reactions. Transfusion and Apheresis
Science, 30, 41–46. https://doi.org/10.1016/j.transci.2003.08.013
Ramachandran, K., & Sirop, P. (2008). Rare complications of diphenhydramine toxicity.
Connecticut Medicine, 72(2), 79–82. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/18306834
Ritchie, J., Lewis, J., McNaughton Nicholls, C., & Ormston, R. (2014). Qualitative Research
Practice : A Guide for Social Science Students and Researchers (2nd ed.). Los Angeles:
SAGE Publications.
Rujkijyanont, P., Monsereenusorn, C., Manoonphol, P., & Traivaree, C. (2018). Efficacy of oral
acetaminophen and intravenous chlorpheniramine maleate versus placebo to prevent red cell
transfusion reactions in children and adolescent with thalassemia: A prospective,
randomized, double-blind controlled trial. Anemia, 2018, 1–8.
https://doi.org/10.1155/2018/9492303
Sandelowski, M. (2000). Whatever happened to qualitative description? Research in Nursing &
Health, 23, 334–340. Retrieved from https://journals-scholarsportalinfo.proxy1.lib.uwo.ca/pdf/01606891/v23i0004/334_whtqd.xml
Sandelowski, M. (2008). Theoretical saturation. In L. M. Given (Ed.), The SAGE Encyclopedia
of Qualitative Research Methods (pp. 875–876). Thousand Oaks, CA: SAGE Publications.
Sanders, R. P., Maddirala, S. D., Geiger, T. L., Pounds, S., Sandlund, J. T., Ribeiro, R. C., …
Howard, S. C. (2005). Premedication with acetaminophen or diphenhydramine for
transfusion with leucoreduced blood products in children. British Journal of Haematology,
130, 781–787. https://doi.org/10.1111/j.1365-2141.2005.05670.x

64

Solh, Z., Chan, A. K. C., & Heddle, N. M. (2016). Transfusion premedication practices among
pediatric health care practitioners in Canada: Results of a national survey. Transfusion,
56(9), 2296–2302. https://doi.org/10.1111/trf.13697
Straus, S. E., Tetroe, J., & Graham, I. (2009). Defining knowledge translation. Canadian
Medical Association Journal, 181, 165–168. https://doi.org/10.1503/cmaj.081229
Suri, H. (2011). Purposeful sampling in qualitative research synthesis. Qualitative Research
Journal, 11(2), 63–76. http://doi.org/10.3316/QRJ1102063
Tobian, A. A. R., King, K. E., & Ness, P. M. (2007). Transfusion premedications: A growing
practice not based on evidence. Transfusion, 47(6), 1089–1096.
https://doi.org/10.1111/j.1537-2995.2007.01242.x
Tracy, S. J. (2010). Qualitative quality: Eight “‘big-tent’” criteria for excellent qualitative
research. Qualitative Inquiry, 16(10), 837–851. https://doi.org/10.1177/1077800410383121
Vaismoradi, M., Turunen, H., & Bondas, T. (2013). Content analysis and thematic analysis:
Implications for conducting a qualitative descriptive study. Nursing & Health Sciences,
15(3), 398–405. https://doi.org/10.1111/nhs.12048
Verster, J. C., Volkerts, E. R., Van Oosterwijck, A. W. A. A., Aarab, M., Bijtjes, S. I. R., De
Weert, A. M., … Verbaten, M. N. (2003). Acute and subchronic effects of levocetirizine
and diphenhydramine on memory functioning, psychomotor performance, and mood. The
Journal of Allergy and Clinical Immunology, 111(3), 623–627.
https://doi.org/10.1067/mai.2003.63
Vossoughi, S., Parker-Jones, S., Schwartz, J., Stotler, B., Schwartz, J., & Stotler, B. (2019).
Provider trends in paediatric and adult transfusion reaction reporting. The International
Journal of Transfusion Medicine, 114(3), 232–236. https://doi.org/10.1111/vox.12758
cBoyer, M. W. (1999). Irradiated donor leukocytes promote engraftment of allogeneic bone
marrow in major histocompatibility complex mismatched recipients without causing graftversus-host disease. Blood, 94, 3222–3233. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/9129056

65

Wang, S. E., Lara, P. N., Lee-Ow, A., Reed, J., Wang, L. R., Palmer, P., … Wun, T. (2002).
Acetaminophen and diphenhydramine as premedication for platelet transfusions: A
prospective randomized double-blind placebo-controlled trial. American Journal of
Hematology, 70, 191–194. https://doi.org/10.1002/ajh.10119
Watts, J. H. (2011). Ethical and practical challenges of participant observation in sensitive health
research. International Journal of Social Research Methodology, 14(4), 301-312.
doi:10.1080/13645579.2010.517658
Whitaker, B. I., Belov, A., & Anderson, S. A. (2019). Progress in US hemovigilance: Can we
still learn from others? Transfusion, 59(2), 433–436. https://doi.org/10.1111/trf.15082
Yazer, M. H., Podlosky, L., Clarke, G., & Nahirniak, S. M. (2004). The effect of prestorage
WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet
concentrates and RBC. Transfusion, 44(1), 10–15. https://doi.org/10.1046/j.00411132.2003.00518.x
Yeh, S. P., Chang, C. W., Chen, J. C., Yeh, W. C., Chen, P. C., Chuang, S. J., … Peng, C. T.
(2011). A well-designed online transfusion reaction reporting system improves the
estimation of transfusion reaction incidence and quality of care in transfusion practice.
American Journal of Clinical Pathology, 136(6), 842–847.
https://doi.org/10.1309/AJCPOQNBKCDXFWU3

66

Appendices
Appendix A: Written Permission to Reprint Figure 1

67

68

69

70

Appendix B: Letter of Information

71

72

73

Appendix C: Interview Guide

74

Appendix D: REB Waiver

75

Curriculum Vitae

Name:

Wenxin Miao

Post-secondary

Master of Health Information Science

Education and

Western University

Degrees:

London, Ontario, Canada
2017-2019

Bachelor of Science
McGill University
Montreal, Quebec, Canada
2013-2017

Related Work

Teaching Assistant

Experience

Western University
2017-2019

Related

Miao, W., Sibbald, S., & Solh, Z. (2019). Understanding nurses’

Publication

perspectives in transfusion reaction management. Poster presented at
Canadian Society for Transfusion Medicine Annual Conference 2019,
Calgary, Canada.

